VANDERBILT UNIVERSITY MEDICAL CENTER
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text VANDERBILT UNIVERSITY MEDICAL CENTER. furp.org, nonprofit organization profile, tax years 2015–2024. https://furp.org/org/vanderbilt-university-medical-center-352528741. Retrieved 2026-11-16.
APA furp.org. (n.d.). VANDERBILT UNIVERSITY MEDICAL CENTER [Nonprofit organization profile; tax years 2015–2024]. Retrieved November 16, 2026, from https://furp.org/org/vanderbilt-university-medical-center-352528741
MLA “VANDERBILT UNIVERSITY MEDICAL CENTER.” furp.org, tax years 2015–2024, https://furp.org/org/vanderbilt-university-medical-center-352528741. Accessed 16 Nov. 2026.
Retrieved 2026-11-16; covers tax years 2015–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
Related institution: Vanderbilt University Exact (hospital)
About (Wikipedia)
Vanderbilt University Medical Center · hospital in Tennessee, United States
The Vanderbilt University Medical Center (VUMC) is a medical provider with multiple hospitals in Nashville, Tennessee, as well as clinics and facilities throughout Middle Tennessee, United States.
- Founded
- 1874
- Type
- hospital
- Website
- http://www.mc.vanderbilt.edu
From Wikipedia, CC BY-SA 4.0 (authors and history); facts from Wikidata (CC0). Matched by the same IRS employer identification number (EIN). Report a wrong match · About this data
2024 · Form 990 · revenue $8.67B ($8.90B in 2025 dollars) · expenses $8.26B · assets $7.79B
- EIN
- 35-2528741
- Address
- 1161 21ST AVE S D3300, NASHVILLE, TN 37232-0011
- Website
- www.vumc.org
- NTEE code
- E20 Hospitals and Related Primary Medical Care Facilities (Health Care) published (IRS Business Master File)
- FURP topic
- science: research education (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- May 2015 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Hospital or medical research organization
- Principal officer
- Scott Phillips (its 2014 Form 990-N)
- Form 990-N e-postcards
- 1 filed, 2014 (organizations with gross receipts normally $50,000 or less file this instead of a full Form 990) IRS data ↗
- Cross-check
- ProPublica Nonprofit Explorer
Mission
See Schedule O Form 990, Part III, Line 1
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
46 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 2015-2024 | $16,481,139 | $57,123,658 | 3 |
| C Wright Pinson | Deputy CEO & Chief Health System Officer | 2015-2024 | $6,637,915 | $34,072,033 | 3 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 2015-2024 | $5,553,898 | $19,850,362 | 2 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 2015-2024 | $4,367,104 | $18,949,384 | 1 |
| Michael J Regier JD | Former General Counsel and Secretary | 2015-2024 | $3,252,689 | $14,455,426 | 1 |
| David S Raiford Md | Former Chief of Clinical Staff | 2016-2024 | $336,679 | $10,390,995 | 1 |
| David R Posch | Former EVP for Population Health | 2016-2024 | $884,055 | $8,881,992 | 3 |
| Zeena M Abdulahad MPA | EVP & Chief Dev Officer | 2018-2024 | $1,816,593 | $7,809,467 | 1 |
| Jennifer A Pietenpol PHD | Chief Scientific and Strategy Officer | 2020-2024 | $2,451,479 | $7,754,666 | 1 |
| Margaret G Rush MD MMHC | Pres & Exec Med Dir, MCJCH | 2019-2024 | $2,074,741 | $7,400,872 | 1 |
| Shon Dwyer MBA RN | Former President, Vanderbilt Adult Hospital | 2020-2024 | $1,230,612 | $7,202,276 | 1 |
| Amir Abtahi MD | Assistant Professor, Department of Orthopaedic Surgery | 2020-2024 | $1,761,416 | $6,891,279 | 1 |
| Ginger Holt MD | Professor, Ortho-Oncology | 2019-2024 | $2,048,363 | $6,515,238 | 1 |
| Thomas S Nantais MBA | Former EVP Adult Ambulatory | 2018-2024 | $468,625 | $5,934,267 | 1 |
| Rick Wright MD | CMO and Sr VP for Clinical Affairs | 2020-2024 | $2,190,236 | $5,715,888 | 1 |
| William W Stead Md | FORMER CHIEF STRATEGY OFFICER (ROLE ENDED DECEMBER 2020) | 2016-2024 | $164,597 | $5,308,487 | 2 |
| Amy Schoeny PHD | Chief HR Officer | 2021-2024 | $1,750,269 | $5,036,097 | 1 |
| Ashish S Shah MD FACS | Professor, Cardiac | 2022-2024 | $1,729,509 | $4,673,446 | 1 |
| Byron Stephens II MD MSCI | Associate Professor, Department of Orthopaedic Surgery | 2023-2024 | $1,933,415 | $3,877,519 | 1 |
| Seth J Karp MD | Professor of Surgery, Biomedical Ethics & Society, and Anesthesiology | 2023-2024 | $1,797,157 | $3,449,834 | 1 |
| Donald Brady MD | Exec Vice Dean - Aca Affairs & Exec VP - Ed Affairs | 2023-2024 | $1,444,930 | $2,456,016 | 1 |
| Lee Ann Liska MBA | Pres & Chief Oper Off at VUH | 2023-2024 | $1,686,132 | $2,364,192 | 1 |
| Wendy Monaci MBA | EVP Adult Ambulatory | 2023-2024 | $1,327,344 | $2,056,464 | 1 |
| Travis Capers FACHE | President of Vanderbilt Regional Community Hospitals | 2022-2024 | $833,711 | $1,933,704 | 1 |
| Cecelia Theobald MD MPH | Chief of Clinical Staff | 2023-2024 | $1,044,446 | $1,647,645 | 1 |
| C J Stimson MD JD | EVP for Population Health (Beginning 1/1/24) | 2024 | $743,084 | $743,084 | 1 |
| Doug Mefford JD | General Counsel and Secretary (Beginning 7/1/24) | 2024 | $661,781 | $661,781 | 1 |
| David Russell | EVP Org Transformation & Chief Strategic Bus Dev Officer (Beginning 9/1/24) | 2024 | $659,795 | $659,795 | 1 |
| Byron F Stephens II MD (former) | Asst Professor Comprehensive Spine Center | 2018-2021 | $2,194,967 | $7,677,617 | 1 |
| Paul Sternberg Jr Md (former) | CMO & VP Clinical Affairs | 2016-2023 | $1,522,708 | $6,311,163 | 3 |
| Traci K Nordberg JD (former) | Chief HR Officer | 2016-2020 | $852,689 | $4,164,301 | 1 |
| Scott L Parker MD (former) | Asst Professor Neurological Surgery | 2018-2019 | $2,035,609 | $4,138,661 | 1 |
| Jacob P Schwarz MD (former) | Asst Professor, Neurological Surgery | 2018-2021 | $1,461,038 | $4,009,544 | 1 |
| Charles L Gregory MA MBA MH (former) | CEO, Monroe Carell Jr. Children's Hospital at Vanderbilt | 2016-2019 | $1,289,425 | $3,555,061 | 1 |
| Paul A Thomas MD (former) | VBJ Faculty - Assoc Professor | 2016-2017 | $1,949,163 | $3,036,538 | 2 |
| Mitchell C Edgeworth MBA (former) | CEO, VANDERBILT UNIVERSITY ADULT HOSPITAL AND CLINICS | 2016-2019 | $416,355 | $2,755,429 | 1 |
| Douglas R Weikert MD (former) | Assoc Professor, Ortho-Hand | 2018-2022 | $1,379,743 | $2,550,847 | 1 |
| Clinton J Devin MD (former) | Comprehensive Spine Center - Assoc Professor | 2016-2017 | $1,510,940 | $2,522,925 | 1 |
| John W Klekamp MD (former) | VBJ Faculty - Asst Professor | 2016-2017 | $1,337,147 | $2,112,783 | 2 |
| Matthew R Fusco BA MD (former) | Asst Professor, Neurological Surgery | 2021 | $1,553,738 | $1,553,738 | 1 |
| Todd R Wurth MD (former) | VBJ Faculty - Asst Professor | 2017 | $1,406,322 | $1,406,322 | 2 |
| Gregory G Polkowski II MD MSCR (former) | Assoc Professor, Ortho-Joints | 2022 | $1,385,116 | $1,385,116 | 1 |
| Gregory G Polkowski II MD (former) | Assoc Professor, Ortho-Joints | 2020 | $1,384,271 | $1,384,271 | 1 |
| David P Bichell MD (former) | Professor, Pediatric Cardiac Surgery | 2022 | $1,325,537 | $1,325,537 | 1 |
| Scott T Arthur MD (former) | VBJ Faculty - Asst Professor | 2017 | $1,300,932 | $1,300,932 | 1 |
| Lloyd G King MD (former) | GI Administration - Asst Professor | 2016 | $774,700 | $774,700 | 2 |
Officers and directors, no compensation reported
24 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| John R Ingram | Director | 2022-2024 | 1 | $0 reported | 11 |
| Daniel Diermeier | Director | 2020-2024 | 2 | $0 reported | 13 |
| Sara J Finley JD | Director, Chair of Mgmt Dev & Comp Comm | 2021-2024 | 2 | $0 reported | 4 |
| Alexander C Taylor | Director | 2021-2024 | 2 | $0 reported | 2 |
| Colin V Reed | Director | 2023-2024 | 2 | $0 reported | 1 |
| Edith Scott Carell Johnson JD | Director, Chair of Board of Dirs & Exec Comm | 2015-2024 | 4 | $0 reported | 1 |
| Gail Carr Williams JD | Director | 2023-2024 | 2 | $0 reported | 1 |
| John F Stein MBA | Director, Vice Chair of Board of Dirs & Chair of Audit & Compl Comm | 2015-2024 | 3 | $0 reported | 2 |
| Lucinda M Baier CPA | Director, Chair of Quality & Safety Com | 2022-2024 | 2 | $0 reported | 1 |
| Makeba Boatwright Williams MD | Director | 2023-2024 | 1 | $0 reported | 1 |
| Makeba Boatwright Williams MD FACOG NCMP (former) | Director (Beginning July 1, 2022) | 2022 | 1 | $0 reported | 1 |
| Michael M E Johns MD (former) | Director | 2015-2022 | 1 | $0 reported | 1 |
| Samuel E Lynch DMD DMSC (former) | Director | 2016-2022 | 1 | $0 reported | 1 |
| Robert C Schiff Jr (former) | Director | 2017-2021 | 1 | $0 reported | 2 |
| Gregory Scott Allen JD (former) | Director | 2017-2021 | 1 | $0 reported | 1 |
| Richard B Johnston Jr MD (former) | Director | 2015-2021 | 1 | $0 reported | 1 |
| Thomas J Sherrard III JD (former) | Director | 2016-2021 | 1 | $0 reported | 1 |
| David W Patterson (former) | Director | 2015-2020 | 1 | $0 reported | 2 |
| Nicholas S Zeppos (former) | Director (Ended August 15, 2019) | 2015-2019 | 1 | $0 reported | 3 |
| Susan R Wente PHD (former) | Director (Beginning August 15, 2019) | 2019 | 1 | $0 reported | 1 |
| Bruce R Evans (former) | Director | 2015-2016 | 1 | $0 reported | 2 |
| Jackson W Moore JD (former) | Director | 2015-2016 | 1 | $0 reported | 2 |
| Samuel E Lynch (former) | Director | 2015 | 1 | $0 reported | 1 |
| Thomas J Sherrard II (former) | Director | 2015 | 1 | $0 reported | 1 |
People by year
2024 · 38 people listed · 28 paid, $67.3M · 38,678 employees · 2,090 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 60 | $14,688,567 | $0 | $1,792,572 | $16,481,139 | 3 |
| C Wright Pinson MD MBA | Deputy CEO & Chief Health System Officer | 59 | $5,621,867 | $0 | $1,016,048 | $6,637,915 | 3 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 60 | $5,018,633 | $0 | $535,265 | $5,553,898 | 2 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 60 | $3,892,160 | $0 | $474,944 | $4,367,104 | 1 |
| Michael J Regier JD | Former General Counsel and Secretary | 0 | $3,018,841 | $0 | $233,848 | $3,252,689 | 1 |
| Jennifer A Pietenpol PHD | Chief Scientific and Strategy Officer | 68 | $2,122,970 | $0 | $328,509 | $2,451,479 | 1 |
| Rick Wright MD | CMO and Sr VP for Clinical Affairs | 32 | $1,872,987 | $0 | $317,249 | $2,190,236 | 1 |
| Margaret G Rush MD MMHC | Pres & Exec Med Dir, MCJCH | 55 | $1,794,599 | $0 | $280,142 | $2,074,741 | 1 |
| Ginger Holt MD | Professor, Ortho-Oncology | 60 | $1,995,013 | $0 | $53,350 | $2,048,363 | 1 |
| Byron Stephens II MD MSCI | Associate Professor, Department of Orthopaedic Surgery | 60 | $1,888,882 | $0 | $44,533 | $1,933,415 | 1 |
| Zeena M Abdulahad MPA | EVP & Chief Dev Officer | 60 | $1,622,435 | $0 | $194,158 | $1,816,593 | 1 |
| Seth J Karp MD | Professor of Surgery, Biomedical Ethics & Society, and Anesthesiology | 60 | $1,745,130 | $0 | $52,027 | $1,797,157 | 1 |
| Amir Abtahi MD | Assistant Professor, Department of Orthopaedic Surgery | 60 | $1,695,468 | $0 | $65,948 | $1,761,416 | 1 |
| Amy Schoeny PHD | Chief HR Officer | 55 | $1,541,038 | $0 | $209,231 | $1,750,269 | 1 |
| Ashish S Shah MD FACS | Professor, Cardiac | 60 | $1,658,970 | $0 | $70,539 | $1,729,509 | 1 |
| Lee Ann Liska MBA | Pres & Chief Oper Off at VUH | 60 | $1,380,360 | $0 | $305,772 | $1,686,132 | 1 |
| Donald Brady MD | Exec Vice Dean - Aca Affairs & Exec VP - Ed Affairs | 50 | $1,213,205 | $0 | $231,725 | $1,444,930 | 1 |
| Wendy Monaci MBA | EVP Adult Ambulatory | 59 | $1,104,937 | $0 | $222,407 | $1,327,344 | 1 |
| Shon Dwyer MBA RN | Former President, Vanderbilt Adult Hospital | 0 | $1,230,612 | $0 | $0 | $1,230,612 | 1 |
| Cecelia Theobald MD MPH | Chief of Clinical Staff | 60 | $876,166 | $0 | $168,280 | $1,044,446 | 1 |
| David R Posch | Former EVP for Population Health | 59 | $831,571 | $0 | $52,484 | $884,055 | 3 |
| Travis Capers FACHE | President of Vanderbilt Regional Community Hospitals | 60 | $806,653 | $0 | $27,058 | $833,711 | 1 |
| C J Stimson MD JD | EVP for Population Health (Beginning 1/1/24) | 50 | $726,509 | $0 | $16,575 | $743,084 | 1 |
| Doug Mefford JD | General Counsel and Secretary (Beginning 7/1/24) | 54 | $508,415 | $0 | $153,366 | $661,781 | 1 |
| David Russell | EVP Org Transformation & Chief Strategic Bus Dev Officer (Beginning 9/1/24) | 60 | $582,909 | $0 | $76,886 | $659,795 | 1 |
| Thomas S Nantais MBA | Former EVP Adult Ambulatory | 0 | $468,625 | $0 | $0 | $468,625 | 1 |
| DAVID S RAIFORD MD | Former Chief of Clinical Staff | 60 | $336,679 | $0 | $0 | $336,679 | 1 |
| WILLIAM W STEAD MD | FORMER CHIEF STRATEGY OFFICER (ROLE ENDED DECEMBER 2020) | 60 | $136,602 | $0 | $27,995 | $164,597 | 2 |
| Alexander C Taylor | Director | 2 | $0 | $0 | $0 | $0 | 2 |
| Colin V Reed | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Daniel Diermeier PHD | Director | 2 | $0 | $0 | $0 | $0 | 13 |
| Edith Scott Carell Johnson JD | Director, Chair of Board of Dirs & Exec Comm | 4 | $0 | $0 | $0 | $0 | 1 |
| Gail Carr Williams JD | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director, Vice Chair of Board of Dirs & Chair of Audit & Compl Comm | 3 | $0 | $0 | $0 | $0 | 2 |
| John R Ingram MBA | Director | 1 | $0 | $0 | $0 | $0 | 11 |
| Lucinda M Baier CPA | Director, Chair of Quality & Safety Com | 2 | $0 | $0 | $0 | $0 | 1 |
| Makeba Boatwright Williams MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Sara J Finley JD | Director, Chair of Mgmt Dev & Comp Comm | 2 | $0 | $0 | $0 | $0 | 4 |
2023 · 35 people listed · 25 paid, $48.1M · 36,145 employees · 1,201 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 50 | $7,614,754 | $0 | $1,528,353 | $9,143,107 | 3 |
| C Wright Pinson MD MBA | Deputy CEO & Chief Health System Officer | 49 | $3,843,576 | $0 | $914,759 | $4,758,335 | 3 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 50 | $2,676,760 | $0 | $445,506 | $3,122,266 | 1 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 50 | $2,281,128 | $0 | $585,147 | $2,866,275 | 2 |
| Shon Dwyer MBA RN | President, Vanderbilt Adult Hospital (Role Ended 6/30/23) | 50 | $2,115,760 | $0 | $163,537 | $2,279,297 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 50 | $1,623,578 | $0 | $433,961 | $2,057,539 | 1 |
| Rick Wright MD | CMO and Sr VP for Clinical Affairs (Beginning 7/1/23) | 49 | $1,761,975 | $0 | $189,499 | $1,951,474 | 1 |
| Byron Stephens II MD MSCI | Associate Professor, Department of Orthopaedic Surgery | 50 | $1,901,976 | $0 | $42,128 | $1,944,104 | 1 |
| Amir Abtahi MD | Assistant Professor, Department of Orthopaedic Surgery | 50 | $1,646,337 | $0 | $61,882 | $1,708,219 | 1 |
| Seth J Karp MD | Professor of Surgery, Biomedical Ethics & Society, and Anesthesiology | 50 | $1,603,707 | $0 | $48,970 | $1,652,677 | 1 |
| Margaret G Rush MD MMHC | Pres & Exec Med Dir, MCJCH | 48 | $1,388,378 | $0 | $262,832 | $1,651,210 | 1 |
| Ashish S Shah MD FACS | Professor, Cardiac | 50 | $1,512,748 | $0 | $65,474 | $1,578,222 | 1 |
| Paul Sternberg Jr MD | CMO & VP Clinical Affairs | 50 | $1,469,781 | $0 | $52,927 | $1,522,708 | 3 |
| Jennifer A Pietenpol PHD | Chief Scientific and Strategy Officer | 50 | $1,285,365 | $0 | $221,788 | $1,507,153 | 1 |
| Zeena M Abdulahad MPA | EVP and Chief Development Officer | 50 | $1,280,713 | $0 | $181,130 | $1,461,843 | 1 |
| DAVID S RAIFORD MD | Chief of Clinical Staff (Role Ended June 30, 2023) | 50 | $1,264,678 | $0 | $124,637 | $1,389,315 | 1 |
| Amy Schoeny PHD | Chief HR Officer | 50 | $1,178,483 | $0 | $193,294 | $1,371,777 | 1 |
| David R Posch | EVP for Population Health | 49 | $1,275,224 | $0 | $52,060 | $1,327,284 | 3 |
| Donald Brady MD | Exec Vice Dean - Aca Affairs & Exec VP - Ed Affairs (Beginning 1/1/23) | 50 | $858,445 | $0 | $152,641 | $1,011,086 | 1 |
| Thomas S Nantais MBA | EVP Adult Ambulatory (Role Ended May 1, 2023) | 50 | $808,361 | $0 | $28,953 | $837,314 | 1 |
| Travis Capers FACHE | President of Vanderbilt Regional Community Hospitals | 50 | $770,423 | $0 | $18,595 | $789,018 | 1 |
| Wendy Monaci MBA | EVP Adult Ambulatory (Beginning 5/1/23) | 49 | $624,369 | $0 | $104,751 | $729,120 | 1 |
| Lee Ann Liska MBA | Pres & Chief Oper Off at VUH (Beginning 7/1/23) | 50 | $630,432 | $0 | $47,628 | $678,060 | 1 |
| Cecelia Theobald MD MPH | Chief of Clinical Staff (Beginning 7/1/23) | 50 | $556,096 | $0 | $47,103 | $603,199 | 1 |
| WILLIAM W STEAD MD | FORMER CHIEF STRATEGY OFFICER (ROLE ENDED DECEMBER 2020) | 50 | $132,375 | $0 | $25,778 | $158,153 | 2 |
| Alexander C Taylor | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Colin V Reed | Director (Beginning 7/1/23) | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel Diermeier PHD | Director | 1 | $0 | $0 | $0 | $0 | 13 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Gail Carr Williams JD | Director (Beginning 7/1/23) | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| John R Ingram MBA | Director | 1 | $0 | $0 | $0 | $0 | 11 |
| Lucinda M Baier CPA | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Makeba Boatwright Williams MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Sara J Finley JD | Director | 1 | $0 | $0 | $0 | $0 | 4 |
2022 · 30 people listed · 20 paid, $35.1M · 35,318 employees · 906 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 50 | $5,488,022 | $0 | $1,439,525 | $6,927,547 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Health System Officer | 49 | $3,383,341 | $0 | $757,224 | $4,140,565 | 3 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 50 | $1,947,456 | $0 | $417,863 | $2,365,319 | 1 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 50 | $1,728,565 | $0 | $537,730 | $2,266,295 | 2 |
| Michael J Regier JD | General Counsel and Secretary | 50 | $1,253,724 | $0 | $418,326 | $1,672,050 | 1 |
| Shon Dwyer MBA RN | President, Vanderbilt Adult Hospital | 50 | $1,189,442 | $0 | $247,683 | $1,437,125 | 1 |
| Thomas S Nantais MBA | EVP Adult Ambulatory | 50 | $1,342,162 | $0 | $91,842 | $1,434,004 | 1 |
| Gregory G Polkowski II MD MSCR | Assoc Professor, Ortho-Joints | 50 | $1,326,555 | $0 | $58,561 | $1,385,116 | 1 |
| Douglas R Weikert MD | Assoc Professor, Ortho-Hand | 50 | $1,321,689 | $0 | $58,054 | $1,379,743 | 1 |
| DAVID S RAIFORD MD | Chief of Clinical Staff | 50 | $1,153,677 | $0 | $218,961 | $1,372,638 | 1 |
| Jennifer A Pietenpol PHD | Chief Scientific and Strategy Officer | 50 | $1,157,047 | $0 | $210,978 | $1,368,025 | 1 |
| Paul Sternberg Jr MD | CMO & VP Clinical Affairs | 50 | $1,317,628 | $0 | $48,364 | $1,365,992 | 3 |
| Ashish S Shah MD FACS | Professor, Cardiac | 50 | $1,307,446 | $0 | $58,269 | $1,365,715 | 1 |
| David P Bichell MD | Professor, Pediatric Cardiac Surgery | 50 | $1,280,738 | $0 | $44,799 | $1,325,537 | 1 |
| Zeena M Abdulahad MPA | EVP and Chief Development Officer | 50 | $1,072,323 | $0 | $168,788 | $1,241,111 | 1 |
| David R Posch | EVP for Population Health | 49 | $1,144,958 | $0 | $46,589 | $1,191,547 | 3 |
| Amy Schoeny PHD | Chief HR Officer | 50 | $1,005,165 | $0 | $181,012 | $1,186,177 | 1 |
| Margaret G Rush MD MMHC | President and Executive Medical Director, Monroe Carell Jr. Children's Hospital at Vanderbilt | 48 | $975,177 | $0 | $203,074 | $1,178,251 | 1 |
| Travis Capers FACHE | President of Vanderbilt Regional Community Hospitals | 50 | $303,763 | $0 | $7,212 | $310,975 | 1 |
| WILLIAM W STEAD MD | FORMER CHIEF STRATEGY OFFICER (ROLE ENDED DECEMBER 2020) | 50 | $128,573 | $0 | $23,100 | $151,673 | 2 |
| Alexander C Taylor | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Daniel Diermeier PHD | Director | 1 | $0 | $0 | $0 | $0 | 13 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| John R Ingram MBA | Director (Beginning July 1, 2022) | 1 | $0 | $0 | $0 | $0 | 11 |
| Lucinda M Baier CPA | Director (Beginning July 1, 2022) | 1 | $0 | $0 | $0 | $0 | 1 |
| Makeba Boatwright Williams MD FACOG NCMP | Director (Beginning July 1, 2022) | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Sara J Finley JD | Director | 1 | $0 | $0 | $0 | $0 | 4 |
2021 · 30 people listed · 19 paid, $38.7M · 33,651 employees · 836 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 50 | $5,461,441 | $0 | $1,326,469 | $6,787,910 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Health System Officer | 48 | $5,056,321 | $0 | $614,854 | $5,671,175 | 3 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 50 | $2,404,355 | $0 | $428,326 | $2,832,681 | 2 |
| Michael J Regier JD | General Counsel and Secretary | 50 | $2,120,568 | $0 | $340,503 | $2,461,071 | 1 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 50 | $1,935,319 | $0 | $379,642 | $2,314,961 | 1 |
| Byron F Stephens II MD | Asst Professor Comprehensive Spine Center | 50 | $2,149,624 | $0 | $45,343 | $2,194,967 | 1 |
| DAVID S RAIFORD MD | Chief of Clinical Staff | 50 | $1,874,969 | $0 | $205,681 | $2,080,650 | 1 |
| Amir M Abtahi MD | Asst Professor Comprehensive Spine Center | 50 | $1,724,162 | $0 | $38,528 | $1,762,690 | 1 |
| Matthew R Fusco BA MD | Asst Professor, Neurological Surgery | 50 | $1,500,160 | $0 | $53,578 | $1,553,738 | 1 |
| Ginger Holt MD | Professor, Ortho-Oncology | 50 | $1,425,422 | $0 | $54,578 | $1,480,000 | 1 |
| Jacob P Schwarz MD | Asst Professor, Neurological Surgery | 50 | $1,445,226 | $0 | $15,812 | $1,461,038 | 1 |
| Jennifer A Pietenpol PHD | Chief Scientific and Strategy Officer | 50 | $1,147,430 | $0 | $201,522 | $1,348,952 | 1 |
| Shon Dwyer MBA RN | President, Vanderbilt Adult Hospital | 50 | $1,064,588 | $0 | $182,055 | $1,246,643 | 1 |
| David R Posch | EVP for Population Health | 49 | $1,126,030 | $0 | $42,853 | $1,168,883 | 3 |
| Zeena M Abdulahad MPA | EVP and Chief Development Officer | 50 | $944,167 | $0 | $158,401 | $1,102,568 | 1 |
| Thomas S Nantais MBA | EVP Adult Ambulatory | 50 | $942,435 | $0 | $136,145 | $1,078,580 | 1 |
| Margaret G Rush MD MMHC | President and Executive Medical Director, Monroe Carell Jr. Children's Hospital at Vanderbilt | 49 | $882,032 | $0 | $167,254 | $1,049,286 | 1 |
| Amy Schoeny PHD | Chief HR Officer | 50 | $628,621 | $0 | $99,253 | $727,874 | 1 |
| WILLIAM W STEAD MD | FORMER CHIEF STRATEGY OFFICER (ROLE ENDED DECEMBER 2020) | 50 | $335,746 | $0 | $24,112 | $359,858 | 2 |
| Alexander C Taylor | Director (Beginning July 1, 2021) | 1 | $0 | $0 | $0 | $0 | 2 |
| Daniel Diermeier PHD | Director | 1 | $0 | $0 | $0 | $0 | 13 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Gregory Scott Allen JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard B Johnston Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert C Schiff Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Sara J Finley JD | Director (Beginning January 1, 2022) | 1 | $0 | $0 | $0 | $0 | 4 |
| Thomas J Sherrard III JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
2020 · 29 people listed · 19 paid, $31.6M · 30,896 employees · 782 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 50 | $4,244,426 | $0 | $1,060,783 | $5,305,209 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Health System Officer | 48 | $2,906,063 | $0 | $578,018 | $3,484,081 | 3 |
| Byron F Stephens II MD | Asst Professor Comprehensive Spine Center | 50 | $2,096,250 | $0 | $41,905 | $2,138,155 | 1 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 50 | $1,630,095 | $0 | $347,626 | $1,977,721 | 1 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 50 | $1,494,326 | $0 | $319,159 | $1,813,485 | 2 |
| Amir M Abtahi MD | Asst Professor Comprehensive Spine Center | 50 | $1,616,798 | $0 | $42,156 | $1,658,954 | 1 |
| Rick W Wright MD | Dept Chairperson Professor, Ortho - Sports Medicine | 50 | $1,544,688 | $0 | $29,490 | $1,574,178 | 1 |
| Ginger Holt MD | Professor, Ortho-Oncology | 50 | $1,418,754 | $0 | $52,898 | $1,471,652 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 50 | $1,189,277 | $0 | $266,463 | $1,455,740 | 1 |
| DAVID S RAIFORD MD | Chief of Clinical Staff | 50 | $1,198,866 | $0 | $191,788 | $1,390,654 | 1 |
| Gregory G Polkowski II MD | Assoc Professor, Ortho-Joints | 50 | $1,336,373 | $0 | $47,898 | $1,384,271 | 1 |
| William W Stead MD | Chief Strategy Officer | 50 | $1,049,951 | $0 | $33,202 | $1,083,153 | 2 |
| Jennifer A Pietenpol PHD | Chief Scientific Officer | 50 | $949,716 | $0 | $129,341 | $1,079,057 | 1 |
| David R Posch | EVP for Population Health | 49 | $1,013,285 | $0 | $38,483 | $1,051,768 | 3 |
| Shon Dwyer MBA RN | President, Vanderbilt Adult Hospital | 50 | $863,205 | $0 | $145,394 | $1,008,599 | 1 |
| Zeena M Abdulahad MPA | EVP and Chief Development Officer | 50 | $850,166 | $0 | $148,600 | $998,766 | 1 |
| Thomas S Nantais MBA | EVP Adult Ambulatory | 50 | $845,775 | $0 | $128,748 | $974,523 | 1 |
| Margaret G Rush MD MMHC | President and Executive Medical Director, Monroe Carell Jr. Children's Hospital at Vanderbilt | 49 | $755,012 | $0 | $109,425 | $864,437 | 1 |
| Traci K Nordberg JD | Chief HR Officer | 0 | $852,689 | $0 | $0 | $852,689 | 1 |
| Daniel Diermeier PHD | Director (Beginning July 1, 2020) | 1 | $0 | $0 | $0 | $0 | 13 |
| David W Patterson MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Gregory Scott Allen JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard B Johnston Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert C Schiff Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Thomas J Sherrard III JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 30 people listed · 19 paid, $26.9M · 29,088 employees · 1,695 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 40 | $2,791,658 | $0 | $718,179 | $3,509,837 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Health System Officer | 40 | $2,226,696 | $0 | $467,764 | $2,694,460 | 3 |
| Byron F Stephens II MD | Asst Professor Comprehensive Spine Center | 40 | $2,076,443 | $0 | $31,509 | $2,107,952 | 1 |
| Scott L Parker MD | Asst Professor Neurological Surgery | 40 | $1,989,189 | $0 | $46,420 | $2,035,609 | 1 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 39 | $1,306,007 | $0 | $285,458 | $1,591,465 | 1 |
| Ginger Holt MD | Professor, Ortho-Oncology | 40 | $1,465,080 | $0 | $50,143 | $1,515,223 | 1 |
| Jacob P Schwarz MD | Asst Professor Neurological Surgery | 40 | $1,393,929 | $0 | $14,261 | $1,408,190 | 1 |
| Paul Sternberg Jr MD | CMO & VP Clinical Affairs | 40 | $1,311,244 | $0 | $37,338 | $1,348,582 | 3 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 40 | $1,065,964 | $0 | $244,539 | $1,310,503 | 2 |
| Charles L Gregory MA MBA MH | CEO, Monroe Carell Jr. Children's Hospital at Vanderbilt | 40 | $1,180,552 | $0 | $108,873 | $1,289,425 | 1 |
| Traci K Nordberg JD | Chief HR Officer | 39 | $1,159,030 | $0 | $117,063 | $1,276,093 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 40 | $905,112 | $0 | $217,880 | $1,122,992 | 1 |
| DAVID S RAIFORD MD | Chief of Clinical Staff | 40 | $908,373 | $0 | $181,882 | $1,090,255 | 1 |
| William W Stead MD | Chief Strategy Officer | 40 | $934,498 | $0 | $27,657 | $962,155 | 2 |
| David R Posch | EVP for Population Health | 38 | $900,512 | $0 | $30,025 | $930,537 | 3 |
| Zeena M Abdulahad MPA | EVP and Chief Development Officer | 40 | $727,053 | $0 | $139,375 | $866,428 | 1 |
| Thomas S Nantais MBA | EVP Adult Ambulatory | 40 | $681,879 | $0 | $116,618 | $798,497 | 1 |
| Margaret G Rush MD MMHC | President and Executive Medical Director, Monroe Carell Jr. Children's Hospital at Vanderbilt | 40 | $551,528 | $0 | $31,419 | $582,947 | 1 |
| Mitchell C Edgeworth MBA | CEO, VANDERBILT UNIVERSITY ADULT HOSPITAL AND CLINICS | 0 | $362,467 | $0 | $53,888 | $416,355 | 1 |
| David W Patterson MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Gregory Scott Allen JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Nicholas S Zeppos JD | Director (Ended August 15, 2019) | 1 | $0 | $0 | $0 | $0 | 3 |
| Richard B Johnston Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert C Schiff Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan R Wente PHD | Director (Beginning August 15, 2019) | 1 | $0 | $0 | $0 | $0 | 1 |
| Thomas J Sherrard III JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 28 people listed · 18 paid, $21.6M · 27,861 employees · 1,700 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 40 | $2,409,508 | $0 | $549,787 | $2,959,295 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Health System Officer | 40 | $1,983,881 | $0 | $373,536 | $2,357,417 | 3 |
| Scott L Parker MD | Asst Professor Neurological Surgery | 40 | $2,058,564 | $0 | $44,488 | $2,103,052 | 1 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 39 | $1,112,882 | $0 | $209,425 | $1,322,307 | 1 |
| Paul Sternberg Jr MD | CMO & VP Clinical Affairs | 40 | $1,213,845 | $0 | $38,446 | $1,252,291 | 3 |
| Byron F Stephens II MD | Asst Professor Comprehensive Spine Center | 40 | $1,204,695 | $0 | $31,848 | $1,236,543 | 1 |
| Douglas R Weikert MD | Asst Professor Ortho-Hand | 40 | $1,128,012 | $0 | $43,092 | $1,171,104 | 1 |
| Jacob P Schwarz MD | Asst Professor Neurological Surgery | 40 | $1,125,742 | $0 | $14,574 | $1,140,316 | 1 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 40 | $923,672 | $0 | $199,755 | $1,123,427 | 2 |
| DAVID S RAIFORD MD | Chief of Clinical Staff | 40 | $816,753 | $0 | $179,391 | $996,144 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 40 | $800,582 | $0 | $177,562 | $978,144 | 1 |
| Mitchell C Edgeworth MBA | CEO, VANDERBILT UNIVERSITY ADULT HOSPITAL AND CLINICS | 40 | $796,635 | $0 | $141,443 | $938,078 | 1 |
| William W Stead MD | Chief Strategy Officer | 40 | $833,967 | $0 | $29,612 | $863,579 | 2 |
| Charles L Gregory MA MBA MH | CEO, Monroe Carell Jr. Children's Hospital at Vanderbilt | 40 | $729,501 | $0 | $132,089 | $861,590 | 1 |
| David R Posch | EVP for Population Health | 38 | $801,455 | $0 | $31,192 | $832,647 | 3 |
| Traci K Nordberg JD | Chief HR Officer | 39 | $633,178 | $0 | $147,693 | $780,871 | 1 |
| Thomas S Nantais MBA | EVP Adult Ambulatory | 40 | $310,736 | $0 | $31,988 | $342,724 | 1 |
| Zeena M Abdulahad MPA | EVP and Chief Development Officer | 40 | $286,486 | $0 | $35,672 | $322,158 | 1 |
| Gregory Scott Allen JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard B Johnston Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| David W Patterson MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert C Schiff Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Thomas J Sherrard III JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Nicholas S Zeppos JD | Director | 1 | $0 | $0 | $0 | $0 | 3 |
2017 · 26 people listed · 16 paid, $21.7M · 26,949 employees · 1,266 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 40 | $2,772,510 | $0 | $293,832 | $3,066,342 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Health System Officer | 40 | $2,171,531 | $0 | $198,900 | $2,370,431 | 3 |
| Paul A Thomas MD | VBJ Faculty - Assoc Professor | 40 | $1,909,278 | $0 | $39,885 | $1,949,163 | 2 |
| Clinton J Devin MD | Comprehensive Spine Center - Assoc Professor | 40 | $1,490,332 | $0 | $20,608 | $1,510,940 | 1 |
| Todd R Wurth MD | VBJ Faculty - Asst Professor | 40 | $1,365,687 | $0 | $40,635 | $1,406,322 | 2 |
| John W Klekamp MD | VBJ Faculty - Asst Professor | 40 | $1,300,953 | $0 | $36,194 | $1,337,147 | 2 |
| Scott T Arthur MD | VBJ Faculty - Asst Professor | 40 | $1,271,113 | $0 | $29,819 | $1,300,932 | 1 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 39 | $1,068,740 | $0 | $111,565 | $1,180,305 | 1 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 40 | $1,018,060 | $0 | $117,677 | $1,135,737 | 2 |
| David S Raiford MD | Chief of Clinical Staff | 40 | $898,656 | $0 | $107,572 | $1,006,228 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 40 | $882,602 | $0 | $105,234 | $987,836 | 1 |
| William W Stead MD | Chief Strategy Officer | 40 | $918,549 | $0 | $29,410 | $947,959 | 2 |
| David R Posch | Executive Vice President for Population Health | 38 | $883,634 | $0 | $30,734 | $914,368 | 3 |
| Mitchell C Edgeworth MBA | CEO, Vanderbilt University Adult Hospital and Clinics | 40 | $812,621 | $0 | $86,371 | $898,992 | 1 |
| Charles L Gregory MA MBA MH | CEO, Monroe Carell Jr. Children's Hospital at Vanderbilt | 40 | $805,478 | $0 | $83,327 | $888,805 | 1 |
| Traci K Nordberg JD | Chief HR Officer | 39 | $703,983 | $0 | $77,932 | $781,915 | 1 |
| Gregory Scott Allen JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard B Johnston Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| David W Patterson MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Robert C Schiff Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Thomas J Sherrard III JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Nicholas S Zeppos JD | Director | 1 | $0 | $0 | $0 | $0 | 3 |
2016 · 26 people listed · 16 paid, $14.9M · 24,567 employees · 1,381 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 40 | $2,802,010 | $0 | $141,262 | $2,943,272 | 3 |
| C Wright Pinson MD MBA | Deputy CEO and Chief Clinical Officer | 40 | $1,864,464 | $0 | $93,190 | $1,957,654 | 3 |
| Paul A Thomas MD | VBJ Faculty - Assoc Professor | 40 | $1,073,481 | $0 | $13,894 | $1,087,375 | 2 |
| Clinton J Devin MD | Comprehensive Spine Center - Assoc Professor | 40 | $1,008,111 | $0 | $3,874 | $1,011,985 | 1 |
| John F Manning Jr PHD MBA | COO and Corporate Chief of Staff | 40 | $892,717 | $0 | $55,344 | $948,061 | 2 |
| Paul J Sternberg Jr MD | CMO & VP Clinical Affairs | 40 | $805,815 | $0 | $15,775 | $821,590 | 3 |
| John W Klekamp MD | VBJ Faculty - Asst Professor | 40 | $762,329 | $0 | $13,307 | $775,636 | 2 |
| Lloyd G King MD | GI Administration - Asst Professor | 39 | $764,186 | $0 | $10,514 | $774,700 | 2 |
| David S Raiford MD | Chief of Clinical Staff | 40 | $674,220 | $0 | $54,212 | $728,432 | 1 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 39 | $652,615 | $0 | $55,321 | $707,936 | 1 |
| William W Stead MD | Chief Strategy Officer | 40 | $607,409 | $0 | $9,951 | $617,360 | 2 |
| David R Posch | Executive Vice President for Population Health | 38 | $570,033 | $0 | $10,870 | $580,903 | 3 |
| Charles L Gregory MA MBA MH | CEO, Monroe Carell Jr. Children's Hospital at Vanderbilt | 40 | $472,004 | $0 | $43,237 | $515,241 | 1 |
| Mitchell C Edgeworth MBA | CEO, Vanderbilt University Adult Hospital and Clinics | 40 | $459,421 | $0 | $42,583 | $502,004 | 1 |
| Traci K Nordberg JD | Chief HR Officer | 40 | $436,013 | $0 | $36,720 | $472,733 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 40 | $417,789 | $0 | $49,576 | $467,365 | 1 |
| Edith Scott Carell Johnson JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard B Johnston Jr MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel E Lynch DMD DMSC | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Bruce R Evans MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Michael M E Johns MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Thomas J Sherrard III JD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein MBA | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Nicholas S Zeppos JD | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Jackson W Moore JD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| David W Patterson MD | Director | 1 | $0 | $0 | $0 | $0 | 2 |
2015 · 15 people listed · none paid · 0 employees · 589 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Jeffrey R Balser MD PHD | President and CEO | 40 | $0 | $0 | $0 | $0 | 3 |
| Bruce R Evans | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Michael M E Johns | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Edith Scott Carell Johnson | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard B Johnston Jr | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel E Lynch | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Jackson W Moore | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| David W Patterson | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Thomas J Sherrard II | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John F Stein | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Nicholas S Zeppos | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| C Wright Pinson MBA MD | Deputy CEO and Chief Clinical Officer | 40 | $0 | $0 | $0 | $0 | 3 |
| John F Manning Jr MBA PHD | COO and Corporate Chief of Staff | 40 | $0 | $0 | $0 | $0 | 2 |
| Cecelia B Moore MHA CPA CHFP | CFO and Treasurer | 40 | $0 | $0 | $0 | $0 | 1 |
| Michael J Regier JD | General Counsel and Secretary | 40 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $234.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $188,970,129 |
| DELL MARKETING LP | Plano, TX | Information Technology | $14,791,378 |
| FRESENIUS MEDICAL CARE HOLDING INC | Boston, MA | Medical Services | $12,625,542 |
| DCI DONOR SERVICES INC | Nashville, TN | Medical Transportation | $9,758,894 |
| BLOOD ASSURANCE INC | Chattanooga, TN | Medical Services | $8,239,431 |
2023 · 5 contractors · $318.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $186,893,638 |
| Cross Country Staffing Inc | Boca Raton, FL | Temporary Labor Services | $49,758,689 |
| THE ROBINS & MORTON GROUP | Brentwood, TN | General Contractor Services | $35,335,332 |
| Trimedx Inc | Indianapolis, IN | Medical Equipment Servicing | $25,938,069 |
| BOTTOMLINE TECHNOLOGIES INC | Portsmouth, NH | Information Technology | $20,921,836 |
2022 · 5 contractors · $403.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $177,738,244 |
| Cross Country Staffing Inc | Boca Raton, FL | Temporary Labor Services | $160,013,795 |
| Trimedx Inc | Indianapolis, IN | Medical Equipment Servicing | $28,980,288 |
| American Foundation for Donation and Transplantation | Richmond, VA | Medical Services | $18,427,222 |
| Deloitte Consulting LLP | New York, NY | Consulting Services | $17,979,298 |
2021 · 5 contractors · $289.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $175,845,639 |
| Cross Country Staffing Inc | Boca Raton, FL | Temporary Labor Services | $52,976,859 |
| Trimedx Inc | Indianapolis, IN | Medical Equipment Servicing | $22,243,751 |
| Messer Construction Co | Nashville, TN | Construction Services | $22,038,637 |
| American Foundation for Donation and Transplantation | Richmond, VA | Medical Services | $16,090,351 |
2020 · 5 contractors · $283.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $175,907,817 |
| Cross Country Staffing Inc | Boca Raton, FL | Temporary Labor Services | $39,598,208 |
| Messer Construction Co | Nashville, TN | Construction Services | $25,437,484 |
| Trimedx Inc | Indianapolis, IN | Medical Equipment Servicing | $24,527,895 |
| Turner Universal Construction Co | Nashville, TN | Construction Services | $17,515,503 |
2019 · 5 contractors · $269.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $175,943,684 |
| Turner Universal Construction Co | Nashville, TN | Construction Services | $43,779,281 |
| The Robins & Morton Group | Brentwood, TN | Construction Services | $24,391,373 |
| Messer Construction Co | Nashville, TN | Construction Services | $15,483,403 |
| EPIC Systems Corporation | Verona, WI | Software Development Services | $10,071,150 |
2018 · 5 contractors · $258.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $178,114,736 |
| Turner Universal Construction Co | Nashville, TN | Construction Services | $47,936,459 |
| Messer Construction Co | Nashville, TN | Construction Services | $11,511,254 |
| NTT Data Services LLC | Bowling Green, KY | Data Services | $10,863,031 |
| EPIC Systems Corporation | Verona, WI | Software Development Services | $9,724,350 |
2017 · 5 contractors · $254.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $189,337,313 |
| Turner Universal Construction Co | Nashville, TN | Construction Services | $29,200,767 |
| Deloitte Consulting LLP | New York, NY | Professional Services | $14,062,823 |
| Cross Country Staffing Inc | Oakland, CA | Staffing Services | $11,551,153 |
| NTT DATA Services LLC | Bowling Green, KY | Data Services | $10,178,821 |
2016 · 5 contractors · $125.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| Vanderbilt University | Nashville, TN | Various Services | $102,728,216 |
| Deloitte Consulting LLP | New York, NY | Professional Services | $7,761,993 |
| Turner Universal Construction Co | Nashville, TN | Construction Services | $6,760,990 |
| Frost-Arnett Company | Nashville, TN | Financial Services | $3,878,643 |
| North Highland Company | Brentwood, TN | Professional Services | $3,854,665 |
Paid as a vendor by
Other organizations that listed this one among their highest-paid independent contractors. Contractor lists give no EIN, so these are matched on name and address; check the filing.
| Year | Paid by | Service | Paid | Filing |
|---|---|---|---|---|
| 2024 | VANDERBILT UNIVERSITY | Affiliation Services | $52,811,861 | view vendor page |
| 2023 | VANDERBILT UNIVERSITY | Affiliation Services | $47,470,165 | view vendor page |
| 2022 | VANDERBILT UNIVERSITY | Affiliation Services | $49,179,252 | view vendor page |
| 2021 | VANDERBILT UNIVERSITY | Affiliation Services | $35,784,617 | view vendor page |
| 2020 | VANDERBILT UNIVERSITY | Affiliation Services | $35,110,306 | view vendor page |
| 2019 | VANDERBILT UNIVERSITY | Affiliation Services | $37,313,908 | view vendor page |
| 2018 | VANDERBILT UNIVERSITY | Affiliation Services | $38,530,913 | view vendor page |
| 2017 | VANDERBILT UNIVERSITY | Affiliation Services | $61,071,344 | view vendor page |
| 2017 | BAPTIST MEMORIAL HOSPITAL TIPTON | PROFESSIONAL SERVICES | $731,042 | view vendor page |
| 2016 | VANDERBILT UNIVERSITY | Affiliation Services | $24,977,060 | view vendor page |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 246 grants to organizations · $125.1M
Listed grants add up to $125,070,227; the return's “grants paid” expense line says $209,048,154. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2023 · 234 grants to organizations · $112.3M
Listed grants add up to $112,281,732; the return's “grants paid” expense line says $180,719,752. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2022 · 277 grants to organizations · $101.2M
Listed grants add up to $101,200,287; the return's “grants paid” expense line says $166,957,184. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2021 · 277 grants to organizations · $112.2M
Listed grants add up to $112,219,858; the return's “grants paid” expense line says $185,663,198. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2020 · 231 grants to organizations · $92.7M
Listed grants add up to $92,704,675; the return's “grants paid” expense line says $151,088,546. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2019 · 224 grants to organizations · $73.6M
Listed grants add up to $73,557,899; the return's “grants paid” expense line says $127,501,010. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2018 · 226 grants to organizations · $71.5M
Listed grants add up to $71,504,713; the return's “grants paid” expense line says $109,070,968. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2017 · 206 grants to organizations · $65.9M
Listed grants add up to $65,948,411; the return's “grants paid” expense line says $105,176,985. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2016 · 183 grants to organizations · $43.9M
Listed grants add up to $43,894,932; the return's “grants paid” expense line says $79,456,591. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2015 · 87 grants to organizations · $5.7M
Listed grants add up to $5,733,357; the return's “grants paid” expense line says $10,479,753. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $8,674,383,028 | $8,258,963,378 | $7,794,199,229 | $2,959,481,167 | $642,858,181 | $7,946,063,108 | $47,069,504 | 38,678 | 2,090 |
| 2023 · Form 990 | ||||||||
| $7,706,035,528 | $7,435,766,434 | $6,568,033,122 | $2,461,736,278 | $588,215,506 | $7,038,743,432 | $34,605,827 | 36,145 | 1,201 |
| 2022 · Form 990 | ||||||||
| $6,921,172,886 | $6,812,818,433 | $5,892,952,923 | $2,113,554,671 | $549,108,462 | $6,286,691,648 | $24,639,622 | 35,318 | 906 |
| 2021 · Form 990 | ||||||||
| $6,413,300,115 | $6,199,085,905 | $5,527,589,693 | $1,920,268,447 | $505,781,347 | $5,830,205,703 | $26,650,372 | 33,651 | 836 |
| 2020 · Form 990 | ||||||||
| $5,574,580,198 | $5,363,708,776 | $5,443,308,715 | $1,730,380,141 | $438,346,168 | $5,106,259,432 | $19,389,907 | 30,896 | 782 |
| 2019 · Form 990 | ||||||||
| $4,930,268,591 | $4,747,491,245 | $5,245,976,412 | $1,401,985,372 | $401,620,114 | $4,496,378,453 | $15,603,388 | 29,088 | 1,695 |
| 2018 · Form 990 | ||||||||
| $4,545,631,286 | $4,323,710,322 | $3,446,397,770 | $1,214,181,802 | $378,866,982 | $4,131,265,400 | $13,014,051 | 27,861 | 1,700 |
| 2017 · Form 990 | ||||||||
| $4,137,532,642 | $4,046,629,245 | $3,192,191,146 | $927,629,601 | $355,841,563 | $3,740,845,973 | $13,227,456 | 26,949 | 1,266 |
| 2016 · Form 990 | ||||||||
| $3,938,189,468 | $3,736,027,030 | $2,801,330,205 | $800,901,923 | $302,808,739 | $3,608,520,465 | $14,241,196 | 24,567 | 1,381 |
| 2015 · Form 990 | ||||||||
| $629,848,993 | $591,892,698 | $2,518,986,311 | $543,176,837 | $47,625,339 | $579,202,171 | $2,301,842 | 0 | 589 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- VANDERBILT UNIVERSITY Nashville, TN · 7 people in common (Alexander C Taylor, Daniel Diermeier, David R Posch)
- NASHVILLE AREA CHAMBER OF COMMERCE Nashville, TN · 3 people in common (C Wright Pinson, Daniel Diermeier, John R Ingram)
- LEADERSHIP NASHVILLE FOUNDATION Nashville, TN · 2 people in common (John F Stein MBA, Sara J Finley JD)
- INGRAM CHARITABLE FUND INC Nashville, TN · 2 people in common (Daniel Diermeier, John R Ingram)
- UNIVERSITY OF CHICAGO Chicago, IL · 1 person in common (Daniel Diermeier)
- THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND New Orleans, LA · 1 person in common (Jeffrey R Balser MD PHD)
- SOUTHEASTERN CONFERENCE Birmingham, AL · 1 person in common (Daniel Diermeier)
- NATIONAL OPINION RESEARCH CENTER Chicago, IL · 1 person in common (Daniel Diermeier)
- THE COMMUNITY FDN OF MIDDLE TN INC Nashville, TN · 1 person in common (Sara J Finley JD)
- FIELD MUSEUM OF NATURAL HISTORY Chicago, IL · 1 person in common (Daniel Diermeier)
- UNIVERSITY OF NASHVILLE MONTGOMERY BELL ACADEMY Nashville, TN · 1 person in common (John R Ingram)
- NASHVILLE SYMPHONY ASSOCIATION Nashville, TN · 1 person in common (Daniel Diermeier)
- MUSIC CITY MAJOR EVENTS INC Nashville, TN · 1 person in common (John R Ingram)
- NASHVILLE ENTREPRENEUR CENTER Nashville, TN · 1 person in common (John R Ingram)
- NASHVILLE NOW EVENTS FOUNDATION Nashville, TN · 1 person in common (John R Ingram)
- UCHICAGO RESEARCH INTERNATIONAL LIMITED Chicago, IL · 1 person in common (Daniel Diermeier)
- HOSPITAL HOSPITALITY HOUSE Nashville, TN · 1 person in common (C Wright Pinson)
- CENTER FOR NONPROFIT MANAGEMENT INC Nashville, TN · 1 person in common (Sara J Finley JD)
- TENNESSEE BUSINESS LEADERSHIP COUNCIL Nashville, TN · 1 person in common (John R Ingram)
- MARTHA & BRONSON INGRAM FOUNDATION Nashville, TN · 1 person in common (John R Ingram)
Funders of this organization
551 grantors reported grants to this organization, $607,779,763 in all, tax years 2010 to 2025; the 25 largest shown (all 551). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| VANDERBILT UNIVERSITY | $333,843,030 | 10 | $54,301,809 | 2024 | 2015-2024 | DAF sponsor | Exact | show |
| UNIVERSITY OF PITTSBURGH | $12,647,120 | 10 | $1,845,112 | 2024 | 2015-2024 | Public charity | Exact | show |
| THE CHICAGO COMMUNITY TRUST | $12,016,000 | 2 | $12,005,000 | 2024 | 2021, 2024 | DAF sponsor | Exact | show |
| WASHINGTON UNIVERSITY | $11,836,001 | 7 | $4,548,609 | 2024 | 2018-2024 | DAF sponsor | Exact | show |
| LEONA M & HARRY B HELMSLEY CHARITABLE TRUST | $9,816,554 | 33 | $1,255,290 | 2024 | 2020-2024 | Private foundation | Fuzzy filed as “VANDERBILT UNIVERSITY MEDICAL CENTER” | show |
| AMERICAN HEART ASSOCIATION INC | $9,784,656 | 7 | $2,041,491 | 2024 | 2020-2024 | Public charity | Exact | show |
| AMERICAN CANCER SOCIETY INC | $7,864,575 | 11 | $45,000 | 2024 | 2016, 2018-2024 | Public charity | Exact | show |
| FRED HUTCHINSON CANCER RESEARCH CENTER | $7,831,199 | 18 | $530,086 | 2021 | 2016-2021 | Public charity | Exact | show |
| YALE UNIVERSITY | $7,661,637 | 9 | $1,902,474 | 2024 | 2016-2024 | DAF sponsor | Exact | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | $7,550,235 | 8 | $1,297,690 | 2024 | 2017-2024 | DAF sponsor | Exact | show |
| THE COMMUNITY FDN OF MIDDLE TN INC | $5,773,725 | 260 | $110,876 | 2024 | 2015-2024 | DAF sponsor | Exact | show |
| CYSTIC FIBROSIS FOUNDATION | $5,206,859 | 28 | $747,060 | 2024 | 2016-2024 | Public charity | Exact | show |
| EMORY UNIVERSITY | $4,672,042 | 9 | $301,696 | 2024 | 2016-2024 | Public charity | Exact | show |
| TENNESSEE RURAL HEALTH RECRUITMENT AND RETENTION CENTER INC | $4,309,436 | 4 | $948,168 | 2024 | 2021-2024 | Public charity | Exact | show |
| TRUSTEES OF BOSTON UNIVERSITY | $4,307,253 | 9 | $1,975,362 | 2024 | 2016-2024 | Public charity | Exact | show |
| HUMAN IMMUNOME PROJECT INC | $3,726,600 | 7 | $9,424 | 2022 | 2018-2020, 2022 | Public charity | Exact | show |
| CROHNS & COLITIS FOUNDATION INC | $3,720,381 | 10 | $212,166 | 2024 | 2014-2015, 2017-2024 | Public charity | Exact | show |
| FAMILY HEALTH INTERNATIONAL | $3,484,261 | 10 | $25,000 | 2023 | 2014-2023 | Public charity | Exact | show |
| BROAD INSTITUTE INC | $3,273,169 | 7 | $691,689 | 2024 | 2018-2024 | Public charity | Exact | show |
| CAL TURNER FAMILY FOUNDATION INC | $3,000,000 | 3 | $1,000,000 | 2024 | 2022-2024 | Private foundation | Fuzzy filed as “VANDERBILT UNIVERSITY MEDICAL CENTER - VUMC” | show |
| RED GATES FOUNDATION | $3,000,000 | 2 | $2,000,000 | 2024 | 2023-2024 | Private foundation | Fuzzy filed as “VANDERBILT UNIVERSITY MEDICAL CENTER” | show |
| DONOR ADVISED CHARITABLE GIVING | $2,906,090 | 9 | $1,094,620 | 2024 | 2016-2024 | DAF sponsor | Exact | show |
| GEORGE WASHINGTON UNIVERSITY | $2,845,803 | 10 | $21,960 | 2024 | 2015-2024 | Public charity | Exact | show |
| LA JOLLA INSTITUTE FOR IMMUNOLOGY | $2,795,140 | 4 | $251,512 | 2024 | 2021-2024 | Public charity | Exact | show |
| UNIVERSITY OF SOUTHERN CALIFORNIA | $2,678,241 | 2 | $1,550,517 | 2024 | 2023-2024 | DAF sponsor | Exact | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| LONG ISLAND JEWISH MEDICAL CENTER | NY | E20 | $4,615,011,448 | $4,456,158,783 | President & CEO | $5,943,362 | Same NTEE code E20, revenue within 2x |
| SENTARA HOSPITALS | VA | E20 | $4,425,929,465 | $3,880,864,246 | DIRECTOR/CHAIR | $6,375,042 | Same NTEE code E20, revenue within 2x |
| KAISER FOUNDATION HEALTH PLAN OF WASHINGTON | WA | E20 | $4,366,355,550 | $4,574,148,986 | Chairman & CEO | $12,976,050 | Same NTEE code E20, revenue within 2x |
| INOVA HEALTH CARE SERVICES | VA | E20 | $6,423,097,177 | $6,013,870,130 | PRESIDENT/CEO | $6,579,451 | Same NTEE code E20, revenue within 2x |
| NYU LANGONE HOSPITALS | NY | E20 | $10,489,477,025 | $9,814,698,011 | EX-OFFICIO, DEAN & CEO | $30,286,568 | Same NTEE code E20, revenue within 2x |
| HIGHMARK HEALTH | PA | E20 | $6,059,666,088 | $5,884,153,492 | CEO, PRESIDENT, & DIRECTOR | $9,716,380 | Same NTEE code E20, revenue within 2x |
| METHODIST HEALTHCARE-MEMPHIS | TN | E20 | $1,968,551,184 | $2,187,722,738 | PRESIDENT/CEO/Board Member | $2,444,821 | Same NTEE code E20, revenue within 5x, same state |
| KECK MEDICAL CENTER OF USC | CA | E20 | $2,156,075,753 | $2,219,233,673 | DIRECTOR | $3,959,981 | Same NTEE code E20, revenue within 5x, similar mission |
| COMMUNITY HEALTH NETWORK INC | IN | E20 | $2,322,217,395 | $1,943,649,051 | DIRECTOR/PRESIDENT & CEO | $3,879,760 | Same NTEE code E20, revenue within 5x, similar mission |
| CARILION MEDICAL CENTER | VA | E20 | $2,324,266,131 | $2,159,987,081 | CEO EMERITUS, CARILION CLINIC | $2,583,851 | Same NTEE code E20, revenue within 5x |
| MILTONS S HERSHEY MEDICAL CENTER | PA | E20 | $3,022,537,247 | $2,723,589,058 | PSH CEO - PART YEAR | $3,235,216 | Same NTEE code E20, revenue within 5x |
| NORTH SHORE UNIVERSITY HOSPITAL | NY | E20 | $3,856,839,202 | $3,750,672,396 | President & CEO | $5,943,362 | Same NTEE code E20, revenue within 5x |
| THOMAS JEFFERSON UNIVERSITY HOSPITAL | PA | E20 | $2,987,121,392 | $2,777,854,723 | TRUSTEE | $1,727,441 | Same NTEE code E20, revenue within 5x |
| METHODIST HOSPITALS OF DALLAS | TX | E20 | $2,549,613,644 | $2,141,829,896 | CEO | $4,078,719 | Same NTEE code E20, revenue within 5x |
| THE METHODIST HOSPITAL | TX | E20 | $3,595,725,127 | $3,282,593,264 | HOSPITAL GROUP RETURN-SCHE | $10,653,219 | Same NTEE code E20, revenue within 5x |
| AVERA MCKENNAN | SD | E20 | $1,859,516,401 | $1,769,469,298 | Orthopedics/Surgery | $1,847,809 | Same NTEE code E20, revenue within 5x |
| COMMONSPIRIT WASHINGTON | AZ | E20 | $1,991,111,655 | $2,001,669,215 | CEO VMFH & PRESIDENT NORTHWEST REGION | $5,754,859 | Same NTEE code E20, revenue within 5x |
| PARK NICOLLET | MN | E20 | $2,192,407,935 | $2,119,364,377 | PRESIDENT & CEO | $3,838,003 | Same NTEE code E20, revenue within 5x |
| ASCENSION HEALTH ALLIANCE | MO | E20 | $3,284,806,032 | $2,096,639,578 | CEO | $14,086,474 | Same NTEE code E20, revenue within 5x |
| HONORHEALTH | AZ | E20 | $3,455,315,312 | $3,179,359,771 | DIRECTOR/PRESIDENT & CEO | $4,422,352 | Same NTEE code E20, revenue within 5x |
| LEXINGTON HEALTH INC | SC | E20 | $1,768,647,290 | $1,707,946,006 | PRESIDENT AND CEO | $4,261,823 | Same NTEE code E20, revenue within 5x |
| YUMA REGIONAL MEDICAL CENTER | AZ | E20 | $1,018,395,867 | $893,523,408 | PRESIDENT/CEO, DIRECTOR | $2,671,867 | Same NTEE code E20, revenue within 10x |
| LOUISIANA CHILDRENS MEDICAL CENTER | LA | E20 | $1,635,655,698 | $1,706,822,808 | PRESIDENT AND CEO | $3,735,208 | Same NTEE code E20, revenue within 10x |
| SAINT ALPHONSUS REGIONAL MEDICAL CENTER INC | ID | E20 | $998,570,100 | $976,839,978 | CARDIOTHORACIC SURGEON | $2,348,068 | Same NTEE code E20, revenue within 10x |
| SOUTH SHORE UNIVERSITY HOSPITAL | NY | E20 | $1,197,432,456 | $1,165,138,079 | President & CEO | $5,943,362 | Same NTEE code E20, revenue within 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $8,258,963,378 spent · pay $4,391,316,563 · grants $209,048,154 · events $17,752,287
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $3,546,950,940 | $3,162,824,148 | $374,983,405 | $9,143,387 | 42.9% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $1,874,299,514 | $1,871,026,920 | $3,272,594 | - | 22.7% |
| Fees: other services | $629,311,085 | $237,988,569 | $390,191,519 | $1,130,997 | 7.6% | |
| Other employee benefits | $450,356,263 | $387,306,515 | $61,120,065 | $1,929,683 | 5.5% | |
| Occupancy | $359,374,384 | $333,720,046 | $24,760,378 | $893,960 | 4.4% | |
| Payroll taxes | $228,542,934 | $196,547,816 | $31,015,884 | $979,234 | 2.8% | |
| Depreciation and depletion | $220,521,693 | $164,425,400 | $56,096,293 | - | 2.7% | |
| Office expenses | $187,084,113 | $157,607,462 | $27,041,149 | $2,435,502 | 2.3% | |
| Information technology | $152,914,827 | $32,760,960 | $119,968,446 | $185,421 | 1.9% | |
| Grants to US organizations and governments | $125,401,782 | $125,401,782 | - | - | 1.5% | |
| Pension plan contributions | $118,119,163 | $101,583,174 | $16,029,893 | $506,096 | 1.4% | |
| Interest | $63,299,700 | $63,016,451 | $41,569 | $241,680 | 0.8% | |
| Grants to US individuals | $55,380,975 | $55,380,975 | - | - | 0.7% | |
| Pay: officers, directors, trustees, key employees | $47,069,504 | $5,267,510 | $39,033,783 | $2,768,211 | 0.6% | |
| Insurance | $39,565,460 | $39,565,040 | - | $420 | 0.5% | |
| All other expenses | $35,909,994 | $30,711,262 | $4,931,856 | $266,876 | 0.4% | |
| Grants outside the US | $28,265,397 | $28,265,397 | - | - | 0.3% | |
| Travel | $21,455,481 | $18,497,694 | $2,908,586 | $49,201 | 0.3% | |
| Advertising and promotion | $19,175,412 | $4,249,570 | $14,908,707 | $17,135 | 0.2% | |
| Fees: legal | $17,514,050 | $2,952,703 | $14,561,347 | - | 0.2% | |
| Conferences, conventions and meetings | $17,072,304 | $13,060,318 | $3,965,347 | $46,639 | 0.2% | |
| Fees: management | $7,582,457 | $3,211,857 | $4,370,600 | - | 0.1% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $6,912,317 | $2,018,231 | $4,433,319 | $460,767 | 0.1% |
| Other (as described) | TAXES (EXCLUDING UBI TAXES) | $5,127,264 | $5,127,264 | - | - | 0.1% |
| Fees: lobbying | $568,143 | $568,143 | - | - | 0.0% | |
| Fees: professional fundraisers | $567,290 | - | - | $567,290 | 0.0% | |
| Pay: disqualified persons | $277,759 | $277,759 | - | - | 0.0% | |
| Fees: accounting | $240,093 | $45,479 | $194,614 | - | 0.0% | |
| Other (as described) | Taxes - UBI | $103,080 | $103,080 | - | - | 0.0% |
| Fundraising events Event | direct expenses; gross income $348,452 | $679,983 | reported apart | |||
| Total | $8,258,963,378 | 100% |
2023 · Form 990 · $7,435,766,434 spent · pay $3,960,634,258 · grants $180,719,752 · events $15,158,736
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $3,165,345,906 | $2,819,752,039 | $336,982,997 | $8,610,870 | 42.6% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $1,649,550,124 | $1,645,628,451 | $3,921,673 | - | 22.2% |
| Fees: other services | $579,049,238 | $227,771,423 | $350,263,227 | $1,014,588 | 7.8% | |
| Other employee benefits | $448,914,663 | $390,926,392 | $56,171,900 | $1,816,371 | 6.0% | |
| Occupancy | $329,161,551 | $290,545,545 | $37,708,448 | $907,558 | 4.4% | |
| Depreciation and depletion | $204,793,283 | $153,006,108 | $51,787,131 | $44 | 2.8% | |
| Payroll taxes | $204,675,470 | $178,236,872 | $25,610,460 | $828,138 | 2.8% | |
| Office expenses | $173,443,073 | $142,397,001 | $28,497,727 | $2,548,345 | 2.3% | |
| Information technology | $138,599,992 | $34,397,193 | $103,997,253 | $205,546 | 1.9% | |
| Grants to US organizations and governments | $112,289,743 | $112,289,743 | - | - | 1.5% | |
| Pension plan contributions | $106,806,678 | $93,009,735 | $13,364,780 | $432,163 | 1.4% | |
| Interest | $68,550,190 | $67,845,671 | $673,975 | $30,544 | 0.9% | |
| Grants to US individuals | $51,277,517 | $51,277,517 | - | - | 0.7% | |
| All other expenses | $42,137,403 | $36,538,041 | $5,196,012 | $403,350 | 0.6% | |
| Pay: officers, directors, trustees, key employees | $34,605,827 | $4,197,606 | $28,141,555 | $2,266,666 | 0.5% | |
| Insurance | $27,240,547 | $27,240,547 | - | - | 0.4% | |
| Travel | $20,463,664 | $17,540,190 | $2,845,324 | $78,150 | 0.3% | |
| Advertising and promotion | $18,381,009 | $4,464,186 | $13,891,933 | $24,890 | 0.2% | |
| Grants outside the US | $17,152,492 | $17,152,492 | - | - | 0.2% | |
| Conferences, conventions and meetings | $14,597,653 | $12,128,274 | $2,320,850 | $148,529 | 0.2% | |
| Fees: legal | $13,139,936 | $1,531,975 | $11,607,961 | - | 0.2% | |
| Fees: management | $6,149,898 | - | $6,149,898 | - | 0.1% | |
| Other (as described) | TAXES (EXCLUDING UBI TAXES) | $4,330,885 | $4,330,885 | - | - | 0.1% |
| Fees: accounting | $2,273,396 | $297,392 | $1,970,004 | $6,000 | 0.0% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $1,627,662 | $1,016,633 | $162,817 | $448,212 | 0.0% |
| Fees: professional fundraisers | $566,195 | - | - | $566,195 | 0.0% | |
| Fees: lobbying | $290,672 | $290,672 | - | - | 0.0% | |
| Pay: disqualified persons | $285,714 | $285,714 | - | - | 0.0% | |
| Other (as described) | UNRELATED BUSINESS INCOME TAXES | $66,053 | $66,053 | - | - | 0.0% |
| Fundraising events Event | direct expenses; gross income $322,057 | $561,083 | reported apart | |||
| Total | $7,435,766,434 | 100% |
2022 · Form 990 · $6,812,818,433 spent · pay $3,697,820,135 · grants $166,957,184 · events $15,336,045
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $3,003,926,750 | $2,684,802,409 | $310,141,246 | $8,983,095 | 44.1% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $1,444,995,774 | $1,443,217,217 | $1,778,557 | - | 21.2% |
| Fees: other services | $525,215,576 | $209,242,225 | $314,672,254 | $1,301,097 | 7.7% | |
| Other employee benefits | $410,659,606 | $355,222,163 | $53,757,628 | $1,679,815 | 6.0% | |
| Occupancy | $302,929,931 | $263,636,871 | $38,354,416 | $938,644 | 4.4% | |
| Depreciation and depletion | $191,046,350 | $144,697,635 | $46,348,715 | - | 2.8% | |
| Payroll taxes | $187,857,408 | $162,498,129 | $24,590,865 | $768,414 | 2.8% | |
| Office expenses | $152,283,910 | $121,769,006 | $28,145,112 | $2,369,792 | 2.2% | |
| Information technology | $121,315,489 | $29,593,086 | $91,549,362 | $173,041 | 1.8% | |
| Grants to US organizations and governments | $111,340,962 | $111,340,962 | - | - | 1.6% | |
| Pension plan contributions | $70,426,264 | $60,917,934 | $9,220,217 | $288,113 | 1.0% | |
| Interest | $68,443,176 | $66,186,007 | $2,257,169 | - | 1.0% | |
| Grants to US individuals | $43,986,432 | $43,986,432 | - | - | 0.6% | |
| Insurance | $31,779,433 | $31,779,433 | - | - | 0.5% | |
| Pay: officers, directors, trustees, key employees | $24,639,622 | $2,994,542 | $20,290,829 | $1,354,251 | 0.4% | |
| All other expenses | $22,689,017 | $18,163,163 | $4,383,480 | $142,374 | 0.3% | |
| Travel | $21,009,237 | $18,527,593 | $2,403,912 | $77,732 | 0.3% | |
| Advertising and promotion | $19,715,437 | $4,402,361 | $14,974,172 | $338,904 | 0.3% | |
| Conferences, conventions and meetings | $14,820,792 | $12,093,462 | $2,666,930 | $60,400 | 0.2% | |
| Fees: legal | $11,840,488 | $5,275,386 | $6,547,781 | $17,321 | 0.2% | |
| Grants outside the US | $11,629,790 | $11,629,790 | - | - | 0.2% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $6,317,985 | - | $5,874,899 | $443,086 | 0.1% |
| Other (as described) | TAXES (Excluding UBI Taxes) | $5,569,555 | $5,569,555 | - | - | 0.1% |
| Fees: management | $5,199,594 | - | $5,199,594 | - | 0.1% | |
| Fees: accounting | $1,518,099 | $172,203 | $1,345,896 | - | 0.0% | |
| Other (as described) | Unrelated Business Income Taxes | $826,002 | $826,002 | - | - | 0.0% |
| Fees: professional fundraisers | $525,269 | - | - | $525,269 | 0.0% | |
| Pay: disqualified persons | $310,485 | $310,485 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $211,511 | $515,253 | reported apart | |||
| Total | $6,812,818,433 | 100% |
2021 · Form 990 · $6,199,085,905 spent · pay $3,304,332,272 · grants $185,663,198 · events $11,084,823
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $2,694,954,749 | $2,397,004,830 | $290,862,096 | $7,087,823 | 43.5% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $1,311,224,380 | $1,307,575,788 | $3,648,592 | - | 21.2% |
| Fees: other services | $488,833,484 | $174,061,136 | $313,907,596 | $864,752 | 7.9% | |
| Other employee benefits | $328,018,988 | $278,482,982 | $48,193,059 | $1,342,947 | 5.3% | |
| Occupancy | $289,270,162 | $260,340,438 | $25,584,853 | $3,344,871 | 4.7% | |
| Depreciation and depletion | $172,999,109 | $130,938,739 | $42,060,370 | - | 2.8% | |
| Payroll taxes | $167,542,459 | $142,241,698 | $24,614,844 | $685,917 | 2.7% | |
| Office expenses | $148,666,129 | $109,841,228 | $35,776,832 | $3,048,069 | 2.4% | |
| Grants to US organizations and governments | $141,572,420 | $141,572,420 | - | - | 2.3% | |
| Information technology | $103,734,445 | $23,482,019 | $80,198,398 | $54,028 | 1.7% | |
| Pension plan contributions | $86,935,620 | $73,806,538 | $12,773,146 | $355,936 | 1.4% | |
| Interest | $65,933,601 | $51,205,695 | $14,727,906 | - | 1.1% | |
| Insurance | $38,466,757 | $38,466,757 | - | - | 0.6% | |
| Grants to US individuals | $34,295,235 | $34,295,235 | - | - | 0.6% | |
| Pay: officers, directors, trustees, key employees | $26,650,372 | $9,524,008 | $15,772,113 | $1,354,251 | 0.4% | |
| Advertising and promotion | $17,821,590 | $5,050,323 | $12,745,470 | $25,797 | 0.3% | |
| All other expenses | $15,903,209 | $17,455,025 | -$1,611,914 | $60,098 | 0.3% | |
| Travel | $12,512,097 | $10,736,923 | $1,747,573 | $27,601 | 0.2% | |
| Conferences, conventions and meetings | $10,761,268 | $8,827,680 | $1,915,559 | $18,029 | 0.2% | |
| Fees: legal | $10,155,483 | $3,345,409 | $6,801,784 | $8,290 | 0.2% | |
| Grants outside the US | $9,795,543 | $9,795,543 | - | - | 0.2% | |
| Other (as described) | TAXES (EXCLUDING UBI TAXES) | $7,788,400 | $7,788,400 | - | - | 0.1% |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $7,262,436 | $3,059,795 | $4,176,470 | $26,171 | 0.1% |
| Fees: management | $4,696,286 | $2,094,607 | $2,601,679 | - | 0.1% | |
| Fees: accounting | $1,737,438 | $458,042 | $1,279,396 | - | 0.0% | |
| Other (as described) | GIFTS AND COMMUNITY CONTRIBUTIONS | $668,252 | $240,650 | $427,602 | - | 0.0% |
| Fees: professional fundraisers | $655,909 | - | - | $655,909 | 0.0% | |
| Pay: disqualified persons | $230,084 | $230,084 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $153,957 | $323,555 | reported apart | |||
| Total | $6,199,085,905 | 100% |
2020 · Form 990 · $5,363,708,776 spent · pay $2,836,543,128 · grants $151,088,546 · events $7,082,757
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $2,282,382,787 | $2,023,981,531 | $251,971,623 | $6,429,633 | 42.6% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $1,118,741,393 | $1,115,522,137 | $3,219,256 | - | 20.9% |
| Fees: other services | $455,585,804 | $159,747,545 | $295,298,304 | $539,955 | 8.5% | |
| Other employee benefits | $313,323,087 | $268,949,236 | $43,091,895 | $1,281,956 | 5.8% | |
| Occupancy | $273,271,557 | $212,436,140 | $57,526,626 | $3,308,791 | 5.1% | |
| Depreciation and depletion | $151,453,709 | $113,759,851 | $37,693,858 | - | 2.8% | |
| Payroll taxes | $144,872,025 | $124,355,105 | $19,924,188 | $592,732 | 2.7% | |
| Office expenses | $143,650,227 | $115,123,832 | $27,074,088 | $1,452,307 | 2.7% | |
| Grants to US organizations and governments | $114,233,405 | $114,233,405 | - | - | 2.1% | |
| Information technology | $79,485,565 | $19,932,906 | $59,539,076 | $13,583 | 1.5% | |
| Pension plan contributions | $76,493,279 | $65,659,720 | $10,520,579 | $312,980 | 1.4% | |
| Interest | $66,642,920 | $60,510,723 | $6,132,197 | - | 1.2% | |
| Grants to US individuals | $30,726,908 | $30,726,908 | - | - | 0.6% | |
| Insurance | $26,267,133 | $26,267,133 | - | - | 0.5% | |
| Pay: officers, directors, trustees, key employees | $19,389,907 | $2,263,543 | $15,772,113 | $1,354,251 | 0.4% | |
| Advertising and promotion | $15,303,736 | $12,206,525 | $2,991,248 | $105,963 | 0.3% | |
| All other expenses | $13,512,880 | $12,551,911 | $900,760 | $60,209 | 0.3% | |
| Conferences, conventions and meetings | $7,061,031 | $5,270,397 | $1,779,850 | $10,784 | 0.1% | |
| Grants outside the US | $6,128,233 | $6,128,233 | - | - | 0.1% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $5,792,301 | $2,995,069 | $2,764,770 | $32,462 | 0.1% |
| Fees: management | $4,849,789 | $1,907,375 | $2,942,414 | - | 0.1% | |
| Other (as described) | TAXES | $4,354,682 | $4,354,682 | - | - | 0.1% |
| Travel | $4,166,419 | $3,324,442 | $827,525 | $14,452 | 0.1% | |
| Fees: legal | $3,539,468 | $1,324,337 | $2,215,131 | - | 0.1% | |
| Fees: accounting | $1,311,078 | $85,995 | $1,225,083 | - | 0.0% | |
| Other (as described) | GIFTS AND COMMUNITY CONTRIBUTIONS | $660,235 | $163,336 | $496,899 | - | 0.0% |
| Fees: professional fundraisers | $427,175 | - | - | $427,175 | 0.0% | |
| Pay: disqualified persons | $82,043 | $82,043 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $42,316 | $21,726 | reported apart | |||
| Total | $5,363,708,776 | 100% |
2019 · Form 990 · $4,747,491,245 spent · pay $2,495,793,963 · grants $127,501,010 · events $9,648,847
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $2,038,776,323 | $1,798,588,560 | $233,756,158 | $6,431,605 | 42.9% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $964,524,592 | $961,650,748 | $2,873,844 | - | 20.3% |
| Fees: other services | $424,339,787 | $152,111,204 | $271,300,230 | $928,353 | 8.9% | |
| Occupancy | $252,945,846 | $197,315,814 | $54,221,310 | $1,408,722 | 5.3% | |
| Other employee benefits | $243,087,877 | $204,711,274 | $37,182,001 | $1,194,602 | 5.1% | |
| Payroll taxes | $128,849,777 | $108,508,186 | $19,708,390 | $633,201 | 2.7% | |
| Depreciation and depletion | $126,654,101 | $95,301,238 | $31,352,863 | - | 2.7% | |
| Office expenses | $123,074,283 | $102,687,740 | $19,012,022 | $1,374,521 | 2.6% | |
| Grants to US organizations and governments | $93,798,504 | $93,798,504 | - | - | 2.0% | |
| Pension plan contributions | $69,405,793 | $58,448,191 | $10,616,510 | $341,092 | 1.5% | |
| Information technology | $69,256,542 | $18,137,199 | $51,099,577 | $19,766 | 1.5% | |
| Interest | $65,481,030 | $59,244,849 | $6,236,181 | - | 1.4% | |
| Grants to US individuals | $29,543,729 | $29,543,729 | - | - | 0.6% | |
| Insurance | $20,775,940 | $20,775,940 | - | - | 0.4% | |
| Pay: officers, directors, trustees, key employees | $15,603,388 | $1,156,217 | $13,115,281 | $1,331,890 | 0.3% | |
| Fees: legal | $14,884,359 | $2,363,900 | $12,520,459 | - | 0.3% | |
| Advertising and promotion | $13,611,546 | $10,905,300 | $2,648,958 | $57,288 | 0.3% | |
| Travel | $13,080,105 | $11,322,790 | $1,706,606 | $50,709 | 0.3% | |
| All other expenses | $10,672,438 | $9,907,766 | $733,225 | $31,447 | 0.2% | |
| Conferences, conventions and meetings | $9,530,092 | $7,935,423 | $1,564,976 | $29,693 | 0.2% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $7,253,992 | $4,082,856 | $2,919,401 | $251,735 | 0.2% |
| Grants outside the US | $4,158,777 | $4,158,777 | - | - | 0.1% | |
| Fees: management | $3,878,253 | $1,496,588 | $2,381,665 | - | 0.1% | |
| Other (as described) | TAXES | $1,938,883 | $1,938,883 | - | - | 0.0% |
| Fees: accounting | $1,186,367 | $235,639 | $950,728 | - | 0.0% | |
| Other (as described) | GIFTS AND COMMUNITY CONTRIBUTIONS | $618,116 | $243,741 | $374,375 | - | 0.0% |
| Fees: professional fundraisers | $490,000 | - | - | $490,000 | 0.0% | |
| Pay: disqualified persons | $70,805 | $70,805 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $192,824 | $118,755 | reported apart | |||
| Total | $4,747,491,245 | 100% |
2018 · Form 990 · $4,323,710,322 spent · pay $2,290,907,193 · grants $109,070,968 · events $13,523,332
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,856,161,359 | $1,615,997,249 | $234,171,047 | $5,993,063 | 42.9% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $812,532,166 | $808,884,199 | $3,647,967 | - | 18.8% |
| Fees: other services | $418,174,238 | $149,349,783 | $268,391,166 | $433,289 | 9.7% | |
| Occupancy | $249,665,198 | $211,257,524 | $35,307,595 | $3,100,079 | 5.8% | |
| Other employee benefits | $239,558,621 | $200,315,283 | $38,206,825 | $1,036,513 | 5.5% | |
| Payroll taxes | $118,325,140 | $107,874,299 | $10,174,809 | $276,032 | 2.7% | |
| Office expenses | $111,128,588 | $86,607,343 | $23,162,437 | $1,358,808 | 2.6% | |
| Depreciation and depletion | $106,524,398 | $78,178,195 | $28,346,203 | - | 2.5% | |
| Grants to US organizations and governments | $77,853,280 | $77,853,280 | - | - | 1.8% | |
| Information technology | $70,776,723 | $17,545,445 | $53,206,994 | $24,284 | 1.6% | |
| Pension plan contributions | $63,800,560 | $44,418,131 | $18,870,491 | $511,938 | 1.5% | |
| Interest | $60,320,340 | $55,301,807 | $5,018,533 | - | 1.4% | |
| Grants to US individuals | $26,744,181 | $26,744,181 | - | - | 0.6% | |
| Travel | $21,376,276 | $19,256,758 | $2,029,106 | $90,412 | 0.5% | |
| Fees: legal | $17,636,705 | $2,414,177 | $15,222,528 | - | 0.4% | |
| Conferences, conventions and meetings | $13,238,385 | $11,355,554 | $1,818,405 | $64,426 | 0.3% | |
| Pay: officers, directors, trustees, key employees | $13,014,051 | $1,548,077 | $11,072,044 | $393,930 | 0.3% | |
| Advertising and promotion | $11,664,951 | $3,565,134 | $7,945,444 | $154,373 | 0.3% | |
| All other expenses | $10,313,024 | $8,533,346 | $1,721,064 | $58,614 | 0.2% | |
| Insurance | $8,953,379 | $8,953,379 | - | - | 0.2% | |
| Grants outside the US | $4,473,507 | $4,473,507 | - | - | 0.1% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $4,007,299 | $2,478,989 | $1,357,695 | $170,615 | 0.1% |
| Fees: management | $3,201,158 | $1,217,899 | $1,983,259 | - | 0.1% | |
| Other (as described) | TAXES | $2,994,578 | $1,538,897 | $1,455,681 | - | 0.1% |
| Fees: accounting | $1,047,888 | $20,805 | $1,027,083 | - | 0.0% | |
| Other (as described) | PROVISION FOR BAD DEBT | $128,308 | $128,308 | - | - | 0.0% |
| Pay: disqualified persons | $47,462 | $47,462 | - | - | 0.0% | |
| Fees: professional fundraisers | $44,900 | - | - | $44,900 | 0.0% | |
| Royalties | $3,659 | $3,659 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $292,902 | $284,947 | reported apart | |||
| Total | $4,323,710,322 | 100% |
2017 · Form 990 · $4,046,629,245 spent · pay $2,179,645,238 · grants $105,176,985 · events $14,845,858
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,769,347,844 | $1,539,107,619 | $225,679,886 | $4,560,339 | 43.7% | |
| Other (as described) | DRUGS AND MEDICAL SUPPLIES | $706,125,249 | $704,428,059 | $1,183,377 | $513,813 | 17.4% |
| Fees: other services | $414,256,213 | $146,280,501 | $267,750,263 | $225,449 | 10.2% | |
| Other employee benefits | $223,028,268 | $187,133,497 | $35,118,547 | $776,224 | 5.5% | |
| Occupancy | $221,145,979 | $179,672,085 | $39,147,663 | $2,326,231 | 5.5% | |
| Payroll taxes | $113,837,188 | $104,147,886 | $9,479,771 | $209,531 | 2.8% | |
| Depreciation and depletion | $105,653,599 | $83,209,120 | $22,444,479 | - | 2.6% | |
| Office expenses | $96,020,388 | $76,712,903 | $17,754,107 | $1,553,378 | 2.4% | |
| Grants to US organizations and governments | $75,516,165 | $75,516,165 | - | - | 1.9% | |
| Information technology | $64,902,238 | $17,200,801 | $47,682,533 | $18,904 | 1.6% | |
| Interest | $62,695,544 | $60,270,777 | $2,424,767 | - | 1.5% | |
| Pension plan contributions | $60,194,103 | $41,875,824 | $17,922,146 | $396,133 | 1.5% | |
| Grants to US individuals | $24,959,549 | $24,959,549 | - | - | 0.6% | |
| Travel | $20,374,713 | $18,077,328 | $2,182,444 | $114,941 | 0.5% | |
| All other expenses | $15,033,707 | $13,132,760 | $1,806,049 | $94,898 | 0.4% | |
| Insurance | $14,565,060 | $14,564,085 | - | $975 | 0.4% | |
| Conferences, conventions and meetings | $14,448,439 | $12,484,036 | $1,911,324 | $53,079 | 0.4% | |
| Pay: officers, directors, trustees, key employees | $13,227,456 | $1,051,968 | $11,729,824 | $445,664 | 0.3% | |
| Advertising and promotion | $12,628,782 | $5,079,861 | $7,522,403 | $26,518 | 0.3% | |
| Other (as described) | OTHER ACADEMIC AND RESEARCH | $6,262,392 | $2,289,428 | $3,858,276 | $114,688 | 0.2% |
| Grants outside the US | $4,701,271 | $4,701,271 | - | - | 0.1% | |
| Other (as described) | TAXES | $3,302,748 | $3,031,220 | $271,528 | - | 0.1% |
| Fees: management | $3,107,781 | $1,238,383 | $1,869,398 | - | 0.1% | |
| Fees: legal | $1,628,163 | $1,410,418 | $217,745 | - | 0.0% | |
| Fees: accounting | $1,058,476 | $23,876 | $1,034,600 | - | 0.0% | |
| Pay: disqualified persons | $10,379 | $10,379 | - | - | 0.0% | |
| Royalties | $4,377 | $4,377 | - | - | 0.0% | |
| Other (as described) | PROVISION FOR BAD DEBTS | -$1,406,826 | -$1,406,826 | - | - | -0.0% |
| Fundraising events Event | direct expenses; gross income $430,692 | $397,419 | reported apart | |||
| Total | $4,046,629,245 | 100% |
2016 · Form 990 · $3,736,027,030 spent · pay $2,035,260,271 · grants $79,456,591 · events $12,101,786
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,644,398,842 | $1,443,663,825 | $195,940,582 | $4,794,435 | 44.0% | |
| Other (as described) | Drugs and Medical Supplies | $640,873,063 | $640,283,950 | $589,113 | - | 17.2% |
| Fees: other services | $361,954,173 | $129,483,857 | $232,253,013 | $217,303 | 9.7% | |
| Occupancy | $220,430,117 | $203,796,724 | $15,915,977 | $717,416 | 5.9% | |
| Other employee benefits | $212,395,693 | $179,912,643 | $31,760,077 | $722,973 | 5.7% | |
| Payroll taxes | $107,629,423 | $98,978,796 | $8,458,091 | $192,536 | 2.9% | |
| Office expenses | $92,060,824 | $71,278,492 | $19,695,350 | $1,086,982 | 2.5% | |
| Depreciation and depletion | $90,316,965 | $78,996,088 | $11,320,877 | - | 2.4% | |
| Information technology | $59,602,944 | $20,608,940 | $38,939,857 | $54,147 | 1.6% | |
| Pension plan contributions | $56,563,820 | $40,103,437 | $16,094,025 | $366,358 | 1.5% | |
| Grants to US organizations and governments | $56,362,300 | $56,362,300 | - | - | 1.5% | |
| Interest | $55,955,845 | $55,153,500 | $802,345 | - | 1.5% | |
| Grants to US individuals | $20,573,873 | $20,573,873 | - | - | 0.6% | |
| Travel | $18,359,273 | $15,948,878 | $2,300,438 | $109,957 | 0.5% | |
| Fees: legal | $17,771,320 | $1,469,653 | $16,301,667 | - | 0.5% | |
| All other expenses | $14,362,135 | $12,256,800 | $1,989,287 | $116,048 | 0.4% | |
| Pay: officers, directors, trustees, key employees | $14,241,196 | $1,441,441 | $12,269,555 | $530,200 | 0.4% | |
| Conferences, conventions and meetings | $11,868,191 | $10,301,896 | $1,530,556 | $35,739 | 0.3% | |
| Insurance | $10,840,978 | $10,840,143 | - | $835 | 0.3% | |
| Advertising and promotion | $10,198,823 | $2,679,947 | $7,494,185 | $24,691 | 0.3% | |
| Other (as described) | Other Academic and Research | $9,196,723 | $5,447,645 | $3,573,261 | $175,817 | 0.2% |
| Fees: management | $2,917,104 | $1,372,377 | $1,544,727 | - | 0.1% | |
| Grants outside the US | $2,520,418 | $2,520,418 | - | - | 0.1% | |
| Other (as described) | Taxes | $2,016,907 | $2,008,743 | $8,164 | - | 0.1% |
| Fees: accounting | $1,409,435 | $2,749 | $1,406,686 | - | 0.0% | |
| Other (as described) | Provision for Bad Debts | $1,073,752 | $1,073,752 | - | - | 0.0% |
| Fees: professional fundraisers | $92,802 | - | - | $92,802 | 0.0% | |
| Pay: disqualified persons | $31,297 | $31,297 | - | - | 0.0% | |
| Royalties | $8,794 | $8,794 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $370,365 | $233,595 | reported apart | |||
| Total | $3,736,027,030 | 100% |
2015 · Form 990 · $591,892,698 spent · pay $312,797,502 · grants $10,479,753 · events $1,802,140
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $257,171,805 | $227,471,721 | $28,757,107 | $942,977 | 43.4% | |
| Other (as described) | Drugs and Medical Supplies | $100,287,575 | $100,144,802 | $142,773 | - | 16.9% |
| Fees: other services | $62,600,951 | $23,595,609 | $38,899,785 | $105,557 | 10.6% | |
| Occupancy | $40,464,361 | $29,831,668 | $10,615,747 | $16,946 | 6.8% | |
| Other employee benefits | $25,291,108 | $21,640,141 | $3,526,237 | $124,730 | 4.3% | |
| Office expenses | $20,188,855 | $17,289,902 | $2,874,992 | $23,961 | 3.4% | |
| Payroll taxes | $15,810,437 | $13,528,101 | $2,204,363 | $77,973 | 2.7% | |
| Depreciation and depletion | $14,089,030 | $12,513,751 | $1,575,279 | - | 2.4% | |
| Pension plan contributions | $12,221,761 | $10,457,473 | $1,704,013 | $60,275 | 2.1% | |
| Interest | $9,534,147 | $8,468,145 | $1,066,002 | $0 | 1.6% | |
| Information technology | $6,095,674 | $3,125,656 | $2,969,207 | $811 | 1.0% | |
| Grants to US organizations and governments | $5,745,472 | $5,745,472 | - | - | 1.0% | |
| All other expenses | $4,534,638 | $4,421,513 | $109,949 | $3,176 | 0.8% | |
| Grants outside the US | $3,261,589 | $3,261,589 | - | - | 0.6% | |
| Travel | $2,932,790 | $2,479,435 | $439,439 | $13,916 | 0.5% | |
| Pay: officers, directors, trustees, key employees | $2,301,842 | $9,000 | $2,211,842 | $81,000 | 0.4% | |
| Conferences, conventions and meetings | $1,800,280 | $1,582,264 | $207,109 | $10,907 | 0.3% | |
| Fees: legal | $1,644,671 | $359,576 | $1,285,095 | - | 0.3% | |
| Insurance | $1,527,852 | $1,526,996 | - | $856 | 0.3% | |
| Grants to US individuals | $1,472,692 | $1,472,692 | - | - | 0.2% | |
| Other (as described) | Other Academic and Research | $1,104,671 | $443,680 | $653,757 | $7,234 | 0.2% |
| Advertising and promotion | $823,593 | $823,512 | - | $81 | 0.1% | |
| Fees: management | $623,177 | $264,007 | $359,170 | - | 0.1% | |
| Other (as described) | Taxes | $220,693 | $207,676 | $13,017 | - | 0.0% |
| Other (as described) | Provision for Bad Debts | $108,828 | $108,828 | - | - | 0.0% |
| Fees: accounting | $33,657 | $15,167 | $18,490 | - | 0.0% | |
| Pay: disqualified persons | $549 | $549 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $33,625 | $1,860 | reported apart | |||
| Total | $591,892,698 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2026 | $230,000 | 3 | |
| 2025 | $320,000 | 4 | |
| 2024 | $260,000 | 5 | |
| 2023 | $160,000 | 4 | |
| 2022 | $150,000 | 4 | |
| 2021 | $130,000 | 4 | |
| 2020 | $120,000 | 4 | |
| 2019 | $160,000 | 4 | |
| 2018 | $455,000 | 4 | |
| 2017 | $424,000 | 5 | |
| 2016 | $240,000 | 5 |
Issues: Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Medicare/Medicaid, Pharmacy, Veterans, Taxation/Internal Revenue Code, Immigration, Insurance, Defense, Foreign Relations, Labor Issues/Antitrust/Workplace
Firms hired: VANDERBILT UNIVERSITY MEDICAL CENTER
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2027 | -$29,846 | $15,406,830 | 17 |
| 2026 | $410,241,921 | $37,587,118 | 839 |
| 2025 | $511,579,194 | $37,974,152 | 864 |
| 2024 | $538,346,508 | $33,513,357 | 903 |
| 2023 | $498,496,621 | $58,409,096 | 861 |
| 2022 | $456,126,612 | $55,155,052 | 811 |
| 2021 | $387,725,678 | $37,552,947 | 812 |
| 2020 | $452,261,537 | $21,686,761 | 754 |
| 2019 | $334,733,945 | $19,386,518 | 718 |
| 2018 | $301,963,666 | $16,635,230 | 664 |
| 2017 | $358,986,238 | $17,053,681 | 620 |
| 2016 | $253,475,309 | $593,854 | 505 |
| 2015 | $7,541,025 | $1,515,000 | 16 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2027 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | HEART TRANSPLANT SERVICES - MODIFICATION TO UPDATE INVOICING INSTRUCTIONS. | $9,471,094 |
| 2027 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | FY27 TASK ORDER | $4,888,828 |
| 2027 | Department of Veterans Affairs | Contract | MEDICAL LABORATORIES 621511 | REAGENTS AND COST PER TESTING | $997,503 |
| 2027 | Department of Veterans Affairs | Contract | TESTING LABORATORIES AND SERVICES 541380 | CORE RESEARCH SUPPORT | $43,243 |
| 2027 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | AUTOPSY ASSISTANT SERVICES ADD DEI 52.222-90 | $9,200 |
| 2027 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | POLICE FORENSICS SERVICES - 06/01/2025 THRU 05/31/2026 AT THE ROBLEY REX VA MEDICAL CENTER LOCATED IN LOUISVILLE, KENTUCKY. | -$3,040 |
| 2027 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/2-DOPAMINERGIC DYSFUNCTION IN LATE-LIFE DEPRESSION (THE D3 STUDY) | -$29,846 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ALL OF US RESEARCH PROGRAM DATA AND RESEARCH CENTER - PROJECT SUMMARY/ABSTRACT - THE ALL OF US RESEARCH PROGRAM’S OVERARCHING GOAL IS TO TRANSFORM OUR UNDERSTA | $22,141,263 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | HEART TRANSPLANT SERVICES - MODIFICATION TO UPDATE INVOICING INSTRUCTIONS. | $19,040,762 |
| 2026 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | VANDERBILT INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH (VICTR) | $10,899,283 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CODA:?COVID AND?DIABETES?ASSESSMENT - PROJECT SUMMARY SEVERAL STUDIES HAVE FOUND THAT INFECTION WITH SARS-COV-2 AND COVID-19 DIAGNOSIS ARE ASSOCIATED WITH THE D | $8,528,886 |
| 2026 | National Institutes of Health | Grant or other assistance | ENVIRONMENTAL HEALTH 93.113 | ECHO LABORATORY CORE AT VANDERBILT FOR INTEGRATED SAMPLE BIOBANKING AND PROCESSING - SUMMARY EARLY-LIFE ENVIRONMENTAL EXPOSURES (E.G., SOCIAL-ENVIRONMENTAL, PAR | $7,870,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) 93.384 | AI-ENABLED GENERATION OF ANTIGEN-SPECIFIC ANTIBODIES | $7,539,882 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CANCER CENTER SUPPORT GRANT | $7,330,508 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | COORDINATION FOR ARDS, PNEUMONIA, AND SEPSIS SUPPORTING TRAINING, ORGANIZATION AND NETWORK EFFICIENCY (CAPSTONE) - THE ARDS, PNEUMONIA, AND SEPSIS (APS) COORDIN | $6,819,289 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | REVERSE-LONG COVID: A MULTICENTER RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL OF IMMUNOMODULATION (WITH BARICITINIB) FOR LONG COVID RELATED ADRD - PROJECT SUM | $6,778,156 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | STATE AND REGIONAL PRIMARY CARE ASSOCIATIONS (PCAS), NATIONAL TECHNICAL ASSISTANCE PROGRAMS (NTAPS), AND HEALTH CENTERED CONTROLLED NETWORKS (HCCNS) 93.129 | REGIONAL AIDS EDUCATION AND TRAINING CENTERS PROGRAM - VANDERBILT UNIVERSITY MEDICAL CENTER (VUMC) PROPOSES TO LEAD THE SOUTHEAST AIDS EDUCATION AND TRAINING CE | $5,633,347 |
| 2026 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | CATALYZING AND HARMONIZING OPERATIONAL INNOVATION FOR RECRUITMENT (CHOIR) - WHILE RECRUITMENT INTO CLINICAL RESEARCH HAS BEEN A LONGSTANDING CHALLENGE FOR NIH F | $5,494,060 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | KIDNEY TRANSPLANT SERVICES - MODIFICATION TO FUND FY26 TO | $5,326,169 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | VANDERBILT ALZHEIMER'S DISEASE RESEARCH CENTER - VANDERBILT ALZHEIMER’S DISEASE RESEARCH CENTER – OVERALL PROJECT SUMMARY WE AIM TO ESTABLISH THE VANDERBILT ALZ | $4,980,453 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | BASE PERIOD OF LIVER/LIVER-KIDNEY AND LIVE DONOR LIVER TRANSPLANT SERVICES | $4,857,173 |
| 2026 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | ENGAGING COOPERATIVE SITES FOR TRIAL ACCELERATION, TRUST, INNOVATION, AND CAPABILITY (ECSTATIC) - CLINICAL RESEARCH COMES IN MANY DIFFERENT SHAPES AND SIZES, AN | $4,827,166 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | EFFECT OF EARLY WEIGHT BEARING ON REHABILITATION OUTCOMES IN PATIENTS WITH UNICONDYLAR PROXIMAL TIBIA FRACTURES AND BIMALLEOLAR ANKLE FRACTURES | $4,670,533 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | VANDERBILT-COORDINATED HUMAN VIROME COLLABORATIVE CENTER (V2C2) - VIRUSES ARE RESPONSIBLE FOR SIGNIFICANT MORBIDITY/MORTALITY AT THE HEART OF MOST OF GLOBAL PAN | $3,995,867 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CLONAL HEMATOPOIESIS AGING RESILIENCY MECHANISMS - PROJECT SUMMARY WITH AGE, DIVIDING CELLS ACQUIRE DNA MUTATIONS. A SMALL NUMBER OF THESE SOMATIC MUTATIONS CON | $3,992,199 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | KINASE MODULATION OF NA+-DEPENDENT CI-COUPLED TRANSPORTERS IN MOUSE KIDNEY | $3,301,901 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TARGETING PATHOGEN RESPIRATION AS AN ANTI-BIOFILM STRATEGY - SUMMARY THIS PROJECT WILL GENERATE PRE-IND VALIDATION DATA FOR A NOVEL COLLECTION OF BACTERIAL META | $3,252,039 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MAPPING CARDIOVASCULAR AND INFECTIOUS RISK OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARATIVE SAFETY - PROJECT SUMMARY/ABSTRACT JANUS KINASE I | $3,213,591 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE INTERSECTION OF IMMUNITY AND CARDIOVASCULAR DISEASES - PROJECT SUMMARY THE OVERALL GOAL OF THE INTERSECTION OF IMMUNITY AND CARDIOVASCULAR DISEASE (IICD) PR | $2,874,543 |
| 2026 | National Institutes of Health | Grant or other assistance | ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) 93.384 | GROUNDBREAKING ORGANIZATION LEVERAGING DATA INSIGHTS: LEARNING FOR OPTIMIZED CRITICAL CARE KNOWLEDGE AND SOLUTIONS (GOLDILOCKS) | $2,796,477 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | CCASANET: CARIBBEAN, CENTRAL AND SOUTH AMERICA NETWORK | $2,785,716 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | VANDERBILT HIV CLINICAL TRIALS UNIT | $2,710,411 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | SOUTHERN ENVIRONMENTAL HEALTH STUDY - SUMMARY APPROXIMATELY 80% OF HUMAN CANCERS ARE CAUSED BY ADVERSE ENVIRONMENTAL EXPOSURES, UNHEALTHY LIFESTYLES AND/OR THE | $2,700,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | VANDERBILT-INGRAM CANCER CENTER SPORE IN GASTROINTESTINAL CANCER | $2,317,951 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EXAMINING STRESS AND AROUSAL ACROSS PUBERTAL DEVELOPMENT IN ASD - PROJECT SUMMARY/ABSTRACT ADOLESCENCE, THE DEVELOPMENTAL TRANSITION OF JUVENILE SOCIAL AND COGN | $2,282,900 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CAUSAL: COHORT TO AUGMENT THE UNDERSTANDING OF SARCOMA SURVIVORSHIP ACROSS THE LIFESPAN - PROJECT SUMMARY SARCOMAS REPRESENT A RARE AND HIGHLY HETEROGENEOUS SUB | $2,186,663 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MULTISCALE FUNCTIONAL ASSESSMENT OF WHITE MATTER ACROSS THE LIFE SPAN - PROJECT SUMMARY/ABSTRACT AGING AND DEVELOPMENT ARE COMPLEX PROCESSES THAT SHAPE THE STR | $2,129,341 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | IDENTIFICATION OF PROTEINS FOR BREAST CANCER RISK: AN INTEGRATIVE EPIDEMIOLOGIC AND GENOMIC STUDY - PROJECT SUMMARY GENOME-WIDE ASSOCIATION STUDIES (GWAS) HAVE | $2,109,503 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TENNESSEE CENTER FOR AIDS RESEARCH (TN-CFAR) | $2,026,894 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE EFFECT OF SERUM PSYCHOTROPIC DRUG LEVELS AND DRUG METABOLIZER STATUS ON DELIRIUM DURATION AND LONG-TERM COGNITION - PROJECT SUMMARY DELIRIUM OCCURS IN ABOUT | $1,937,375 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VANDERBILT DIABETES RESEARCH CENTER | $1,776,785 |
| 2026 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | SOUTHEAST TRANSLATIONAL ALCOHOL AND HIV RESEARCH CENTER (STAHR CENTER) - PEOPLE WITH HIV (PWH) HAVE A TWO-FOLD EXCESS RISK OF CARDIOVASCULAR DISEASE (CVD) AS CO | $1,775,091 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TBX4-DRIVEN PULMONARY HYPERTENSION: MECHANISMS AND THERAPEUTIC TARGETS - PROJECT SUMMARY: HETEROZYGOUS RARE VARIANTS IN TBX4 ARE THE SECOND MOST COMMON CAUSE OF | $1,774,674 |
| 2026 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | SEVERE CUTANEOUS ADVERSE REACTION (SCAR) CLINICAL RESEARCH CONSORTIUM (CRC) - SEVERE CUTANEOUS ADVERSE REACTIONS CLINICAL RESEARCH CONSORTIUM (SCAR-CRC) OVERALL | $1,761,085 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THERAPEUTIC DEVELOPMENT OF THE RYR2-INHIBITOR ENT-VERTICILIDE FOR ATRIAL FIBRILLATION - THERAPEUTIC DEVELOPMENT OF THE RYR2-INHIBITOR ENT-VERTICILIDE FOR ATRIAL | $1,732,198 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATHOPHYSIOLOGICAL ROLE OF MITOCHONDRIAL CYCLOPHILIN D ACETYLATION IN VASCULAR DYSFUNCTION AND HYPERTENSION - PROJECT SUMMARY NEARLY HALF OF ADULTS HAVE HYPERTE | $1,726,634 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE CONTRIBUTION OF SUPEROXIDE INFLUX VIA LRRC8 ANION CHANNELS TO INFECTIOUS VASCULAR DYSFUNCTION - PROJECT SUMMARY SEPSIS, THE SYSTEMIC INFLAMMATORY RESPONSE O | $1,717,737 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | NEUROPROTECTIVE EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN ALZHEIMER'S DISEASE | $1,705,551 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | H. PYLORI-INDUCED INFLAMMATION AND GASTRIC CANCER | $1,694,664 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | COMPARISON OF HIGH VS. STANDARD DOSE INFLUENZA VACCINE IN PEDIATRIC SOLID ORGAN TRANSPLANT RECIPIENTS - PROJECT SUMMARY INFLUENZA VIRUS IS A SIGNIFICANT PATHOGE | $1,631,637 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | PROJECT TITLE: GLUCAGONLIKE PEPTIDE-1 RECEPTOR AGONISTS TO ATTENUATE METABOLIC RISK IN INDIVIDUALS WITH DUCHENNE MUSCULAR DYSTROPHY | $1,620,023 |
| 2026 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | IMPROVING CLINICIAN-AI TEAMING THROUGH ALGORITHMOVIGILANCE CHECKPOINTS FOR TRUST AND SAFETY (ACTS) - OUR PROPOSAL ADDRESSES THE URGENT NEED FOR METHODS TO ENHAN | $1,575,000 |
| 2026 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | SUSTAINABLE ALGORITHMS FOR GENERALIZABLE AND EFFECTIVE (SAGE) LEARNING PREDICTION SYSTEMS THAT DELIVER ON THE PROMISE OF AI FOR ALL PATIENTS AND COMMUNITIES - P | $1,575,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | VANDERBILT ANTIBODY AND ANTIGEN DISCOVERY FOR CLOSTRIDIOIDES DIFFICILE VACCINES - OVERALL PROJECT SUMMARY VANDERBILT ANTIBODY AND ANTIGEN DISCOVERY FOR CLOSTRID | $1,570,047 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | SHAPING OF THE MICROENVIRONMENT IN COLONIC PRE-CANCER BY EPITHELIA AND MICROBIOTA - THE VANDERBILT TBEL CENTER ASSEMBLES A MULTI-DISCIPLINARY TEAM OF FIELD-SPEC | $1,534,280 |
| 2026 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | MAPPING AND OPTIMIZING HEALTHCARE PROFESSIONAL INTERACTION NETWORKS FROM EHR DATA AND LOGS THROUGH HUMAN-AI COLLABORATION - PROJECT SUMMARY HEALTHCARE PROFESSIO | $1,521,723 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | ECHO RENEWAL FOR THE INSPIRE STUDY COHORT - THE OVERARCHING GOALS OF THIS PROPOSAL ARE (1) TO MAINTAIN RETENTION OF CHILDREN IN THE INSPIRE BIRTH COHORT WITH EM | $1,517,423 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HOST AND VIRAL DETERMINANTS OF INFANT AND CHILDHOOD ALLERGY AND ASTHMA | $1,496,183 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | USDHUB: COMMUNITY RESOURCE FOR URINARY STONE DISEASE RESEARCH - ABSTRACT URINARY STONE DISEASE (USD) IS HIGHLY PREVALENT AND CONTRIBUTES A SUBSTANTIAL PROPORTIO | $1,494,428 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | COORDINATION FOR DEMONSTRATING REAL-WORLD ADVANCEMENT IN GENOMICS OPERATIONS NETWORK (DRAGON) - THE NETWORK OF GENOMICS-ENABLED LEARNING HEALTHCARE SYSTEMS (GLH | $1,473,099 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | ANVIL CLINICAL ENVIRONMENT FOR INNOVATION AND TRANSLATION (ACE-IT) - PROJECT SUMMARY THE ANALYSIS, VISUALIZATION, AND INFORMATICS LAB-SPACE (ANVIL) PLATFORM IS | $1,429,420 |
| 2026 | Department of Veterans Affairs | Contract | MEDICAL LABORATORIES 621511 | STAT REFERENCE TESTING FOR TRANSPLANT PATIENTS UPDATE THE CLINS FOR THE ELECTRONICAL CONTRACT MANAGEMENT SYSTEM | $1,423,287 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | GENETIC AND STRUCTURAL BASIS FOR VIRUS NEUTRALIZATION | $1,395,022 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE ADAPT TRIAL: ADAPTING EVIDENCE-BASED OBESITY INTERVENTIONS IN COMMUNITY SETTINGS - PROJECT SUMMARY EVIDENCE-BASED OBESITY TREATMENT IS INACCESSIBLE TO MOST | $1,380,245 |
| 2026 | Centers for Disease Control and Prevention | Grant or other assistance | DISABILITIES PREVENTION 93.184 | TENNESSEE ADDM: ENHANCING PUBLIC HEALTH SURVEILLANCE OF AUTISM SPECTRUM DISORDER THROUGH THE AUTISM AND DEVELOPMENTAL DISABILITIES MONITORING (ADDM) NETWORK - A | $1,371,410 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ROLE OF IGE IN HUMAN DISEASE AND IMMUNITY TO TICKS - PROJECT SUMMARY THERE IS A GROWING BODY OF EVIDENCE THAT THE ALLERGIC IMMUNE RESPONSE IS DIRECTED TOWARD EC | $1,356,673 |
| 2026 | Centers for Disease Control and Prevention | Contract | GENERAL MEDICAL AND SURGICAL HOSPITALS 622110 | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | $1,337,071 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | THE ELECTRONIC MEDICAL RECORDS AND GENOMICS (EMERGE) NETWORK PHASE III - COORDINATING CENTER (U01) | $1,331,038 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MOLECULAR AND CELLULAR BASIS FOR DIGESTIVE DISEASES | $1,274,882 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | SOUTHERN COMMUNITY COHORT STUDY - ABSTRACT WE ARE SUBMITTING THIS APPLICATION TO SEEK CONTINUED SUPPORT FOR THE SOUTHERN COMMUNITY COHORT STUDY (SCCS) AND TO TE | $1,249,181 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | VANDERBILT INTEGRATED CENTER OF EXCELLENCE IN MATERNAL AND PEDIATRIC PRECISION THERAPEUTICS (VICE-MPRINT) - PROJECT SUMMARY / ABSTRACT - OVERALL THERE IS A RAPI | $1,237,710 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | GENETIC VARIANT EVIDENCE USING NOVEL TOOLS TO ELUCIDATE PATHOPHYSIOLOGY: ACCELERATING TRANSLATION TO HEALTH (GENEPATH) - THE ML/AI TOOLS TO ADVANCE GENOMIC TRAN | $1,193,092 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | OPTIMIZING LUNG CANCER SCREENING GUIDELINES FOR ALL AMERICANS | $1,166,003 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | OVERALL: EUNICE KENNEDY SHRIVER INTELLECTUAL AND DEVELOPMENTAL DISABILITIES RESEARCH CENTER AT VANDERBILT | $1,150,489 |
| 2026 | National Institutes of Health | Grant or other assistance | NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350 | INSTITUTIONAL CAREER DEVELOPMENT CORE | $1,127,194 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PATHOGEN AND HOST PREDICTORS OF M. TUBERCULOSIS TRANSMISSION - PROJECT SUMMARY COMMON WAYS TO MEASURE M. TUBERCULOSIS TRANSMISSION ARE VIA ACQUISITION OF TH1-SK | $1,123,791 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | GLP-1R AGONIST IMMUNE TARGETS IN LEAN AND OBESITY-ASSOCIATED ASTHMA - PROJECT SUMMARY MULTIPLE PRECLINICAL AND CLINICAL STUDIES SHOW THAT GLUCAGON-LIKE PEPTIDE- | $1,116,293 |
| 2026 | Department of Education | Grant or other assistance | RESEARCH IN SPECIAL EDUCATION 84.324 | PROJECT TASK: IMPROVING TRANSITION PLANNING FOR STUDENTS WITH AUTISM SPECTRUM DISORDER BY ENHANCING ACCESS, SKILLS, AND KNOWLEDGE | $1,105,228 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF SIK3 IN PKA/MTORC1 REGULATION OF ADIPOSE BROWNING - PROJECT SUMMARY: . OBESITY IS AT EPIDEMIC PROPORTIONS IN THE US. OVER 60% OF THE POPULATION IS EITHE | $1,081,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | TENNESSEE VALLEY COOPERATIVE HUMAN TISSUE NETWORK | $1,050,025 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTEGRATED APPROACH TO STUDY EARLY AND LATE EVENTS IN COLONIC NEOPLASIA: MOUSE TO MAN | $1,042,889 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | LIVER/LIVER-KIDNEY TRANSPLANT SERVICES | $1,017,161 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | VANDERBILT CENTER FOR UNDIAGNOSED DISEASES (VCUD) - PROJECT SUMMARY UNDIAGNOSED DISEASES (UD) ARE CONSTELLATIONS OF SIGNIFICANT SIGNS, SYMPTOMS AND/OR TEST RESU | $1,010,335 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGIONAL PROSPECTIVE OBSERVATIONAL RESEARCH IN TUBERCULOSIS (REPORT) ? BRAZIL NETWORK - PROJECT SUMMARY BRAZIL HAS THE HIGHEST TUBERCULOSIS (TB) BURDEN IN THE W | $1,000,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | VANDERBILT UNIVERSITY MEDICAL CENTER (VUMC) COFAR CLINICAL RESEARCH CENTER - PROJECT SUMMARY/ABSTRACT THIS APPLICATION IS IN RESPONSE TO RFA-AI-22-076 TO ESTABL | $991,198 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HARMONIST: A SCALABLE TOOLKIT FOR STANDARDIZING AND COORDINATING DATA SHARING ACROSS INTERNATIONAL RESEARCH NETWORKS | $976,538 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE SOUTHEASTERN ACUTE KIDNEY INJURY (SEAK) ALLIANCE FOR THE COPE-AKI CONSORTIUM - ACUTE KIDNEY INJURY (AKI) IS AN ENORMOUS PUBLIC HEALTH PROBLEM THAT AFFECTS U | $952,935 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | VANDERBILT CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM | $931,584 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CELLULAR AND MOLECULAR COORDINATION OF ALVEOLAR REGENERATION - PROJECT SUMMARY THE LUNG IS EXPOSED TO NUMEROUS INJURIOUS STIMULI THROUGHOUT LIFE, INCLUDING INFE | $917,304 |
| 2026 | Centers for Disease Control and Prevention | Contract | GENERAL MEDICAL AND SURGICAL HOSPITALS 622110 | (CISA) HOME LAIV STUDY - CONTRIBUTING SITE, EO 14398 | $912,943 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | UNRAVELING THE MOLECULAR ORIGINS OF CHRONIC PARENCHYMAL LUNG DISEASES - PROJECT SUMMARY: SINGLE-CELL GENOMIC STUDIES HAVE TRANSFORMED OUR UNDERSTANDING OF THE C | $893,029 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | PHYSICAL ACTIVITY INTERVENTION TO IMPROVE SURGICAL SPINE OUTCOMES (PASS) - PROJECT ABSTRACT DEGENERATIVE SPINAL CONDITIONS ARE A MAJOR PUBLIC HEALTH BURDEN CONT | $891,026 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | IMMUNOGENICITY AND SAFETY OF HIGH-DOSE VS. STANDARD-DOSE INFLUENZA VACCINES ADMINISTERED OVER CONSECUTIVE SEASONS TO LUNG TRANSPLANT RECIPIENTS - PROJECT SUMMAR | $887,964 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMPLEMENTING TIGHT BLOOD PRESSURE CONTROL IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION - CHRONIC HYPERTENSION (CHTN) COMPLICATES 2-3% OF PREGNANCIES IN THE UNITE | $887,207 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EMERGENCY DEPARTMENT TELEHEALTH FOR IMPROVING OUTCOMES RELATED TO SUICIDE (ETHOS) - PROJECT SUMMARY/ABSTRACT CHILDREN AND ADULTS IN THE US ARE INCREASINGLY SEEK | $884,315 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CARNITINE SUPPLEMENTATION IN PULMONARY ARTERIAL HYPERTENSION - RIGHT VENTRICULAR (RV) FAILURE IS THE MOST COMMON CAUSE OF DEATH IN PULMONARY ARTERIAL HYPERTENSI | $874,973 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROBING MECHANISTIC LINKS BETWEEN ENDOTHELIAL AGING AND DEMENTIA - PROJECT SUMMARY THE MISSION OF OUR LABORATORY IS TO PURSUE ANSWERS TO ESSENTIAL QUESTIONS IN | $874,948 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPMENT OF CROSS-PROTECTIVE ANTIBODIES FOR RESPIRATORY VIRUSES OF BIOMEDICAL SIGNIFICANCE - PROJECT SUMMARY HUMAN RESPIRATORY VIRUSES CONTINUE TO PRESENT A | $874,823 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INVESTIGATING TRANSCRIPTIONAL MECHANISMS OF FIBROSIS IN THE LIVER - PROJECT SUMMARY: METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH), AN ADVANCED FORM O | $874,741 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PERSONALIZED OXYGEN THERAPY FOR CRITICALLY ILL ADULTS: A RANDOMIZED TRIAL - PROJECT SUMMARY / ABSTRACT EACH YEAR, 2-3 MILLION CRITICALLY ILL ADULTS IN THE UNITE | $874,123 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE GUT MICROBIOME, METABOLOME AND SALT-SENSITIVITY OF BLOOD PRESSURE - PROJECT SUMMARY / ABSTRACT SALT-SENSITIVITY OF BLOOD PRESSURE (SSBP), QUANTIFIED AS THE | $874,014 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | USING REAL-WORLD DATA TO EVALUATE MODERN PHARMACOTHERAPY TREATMENT REGIMENS AND PROPHYLAXIS FOR REDUCING INFECTIONS IN SICKLE CELL DISEASE - PROJECT SUMMARY/ABS | $873,449 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | BREAST CANCER GENETIC STUDY IN AFRICAN-ANCESTRY POPULATIONS | $873,371 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMPROVING DISEASE SUBTYPING AND PHYSIOLOGICAL CHARACTERIZATION OF ADULT-ONSET DIABETES IN ELECTRONIC HEALTH RECORDS - ABSTRACT DIABETES IS BROADLY CLASSIFIED AS | $867,269 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NON-CANONICAL EPHB2-MEDIATED SIGNALING IN AKI AND ITS PROGRESSION TO CKD - TRANSFORMING GROWTH FACTOR (TGF)-Β PROMOTES INFLAMMATORY AND FIBROTIC RESPONSES VIA A | $866,265 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | RATIONAL INTEGRATION OF POLYGENIC RISK SCORES (RIPS) - PROJECT SUMMARY THERE HAS BEEN EXTRAORDINARY GROWTH IN NEW TECHNIQUES TO PREDICT COMMON, COMPLEX DISEASE | $863,677 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EFFECT OF INFANT ANTIBIOTICS ON THE DEVELOPMENT OF THE EARLY-LIFE AIRWAY AND GUT MICROBIOME AND RISK OF CHILDHOOD ASTHMA - PROJECT SUMMARY THE USE OF ANTIBIOTIC | $859,471 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CARE, REVIEW, ASSESSMENT AND FEEDBACK TOOL IN ACUTE RESPIRATORY INFECTIONS (CRAFT-IAR) - UNNECESSARY ANTIBIOTIC PRESCRIBING IS A POTENTIALLY AVOIDABLE SOURCE OF | $858,071 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THERAPEUTIC DEVELOPMENT OF RYR2-INHIBITING FLECAINIDE ANALOGS FOR ARRHYTHMIA PREVENTION - PROJECT SUMMARY SUDDEN CARDIAC DEATH, OFTEN CAUSED BY VENTRICULAR ARR | $856,721 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PATHOPHYSIOLOGY OF METABOLICALLY DETRIMENTAL CHANGES IN ADIPOSE DISTRIBUTION, ADIPOCYTE FUNCTION, AND ADIPOSE IMMUNE ENVIRONMENT ON ANTIRETROVIRAL THERAPY - ABS | $856,050 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | SYSTEMATICALLY SCREENING AND VALIDATING DRUG REPURPOSING CANDIDATES FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIAS - ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (A | $851,582 |
| 2026 | Department of Veterans Affairs | Contract | TESTING LABORATORIES AND SERVICES 541380 | CORE RESEARCH SUPPORT | $850,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNOLOGIC AND ANTIGENIC DRIVERS OF IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS - PROJECT SUMMARY/ABSTRACT THIS PROPOSAL BRINGS TOGETHER DR. JAVID MOSLE | $849,674 |
| 2026 | National Institutes of Health | Grant or other assistance | NURSING RESEARCH 93.361 | ADVANCING WORKLOAD MEASUREMENT IN CRITICAL CARE TO IMPROVE PATIENT SAFETY AND CLINICIAN WELL-BEING - STRUCTURED ABSTRACT BACKGROUND. HIGH WORKLOAD IN INTENSIVE | $847,912 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TECHNOLOGIES FOR HIGH-THROUGHPUT MAPPING OF ANTIGEN SPECIFICITY TO B-CELL-RECEPTOR SEQUENCE - PROJECT SUMMARY. THE HUMAN IMMUNE SYSTEM PARTICIPATES IN COMPLEX I | $841,663 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IDENTIFICATION OF EARLY HFPEF AFTER PREECLAMPSIA BY EXERCISE STRESS TESTING - ABSTRACT PREGNANCY IS A UNIQUE, EARLY MOMENT OF CARDIOVASCULAR STRESS IN YOUNG WOM | $841,313 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DISSECTING METABOLIC FUNCTIONS OF MITOCHONDRIAL ELECTRON TRANSPORT IN KIDNEY EPITHELIUM - THE KIDNEY TRANSPORTS IONS, SOLUTES, AND WATER THROUGH ENERGY-INTENSIV | $833,970 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS OF ENTERIC NEURON DIVERSIFICATION - NORMAL GASTROINTESTINAL (GI) MOTILITY IS AN ESSENTIAL PREREQUISITE FOR NUTRIENT ABSORPTION, FECAL ELIMINATION AND | $833,211 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | KIDNEY TARGETED AAV FOR GENE THERAPY - THE KIDNEY REMAINS UNDERSTUDIED AS A TARGET ORGAN FOR IN VIVO GENE TRANSFER LEADING TO A LACK OF EFFECTIVE GENE THERAPIES | $832,790 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TARGETING RESIDUAL ASCVD RISK BY INTEGRATING GENETICS AND CLINICAL DATA - PATIENTS REGULARLY HAVE MYOCARDIAL INFARCTIONS OR STROKES, DESPITE BEING ON TREATMENT | $831,571 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | THE DUAL ROLE OF MEMORIZATION: COMPUTATIONAL METHODS FOR BALANCING MODEL PERFORMANCE AND PRIVACY PROTECTION IN AI - PROJECT SUMMARY RAPID ADVANCES IN ARTIFICIAL | $831,250 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | ALIGNING EVIDENCE AND PRACTICE: COMPARING BUPRENORPHINE DOSING AND CLINICAL OUTCOMES ACROSS PREGNANT AND NON-PREGNANT POPULATIONS - PROJECT ABSTRACT – VANDERBIL | $825,492 |
| 2026 | National Institutes of Health | Grant or other assistance | 21ST CENTURY CURES ACT - BRAIN RESEARCH THROUGH ADVANCING INNOVATIVE NEUROTECHNOLOGIES 93.372 | BIOPHYSICAL AND NEURAL BASIS OF FOCUSED ULTRASOUND STIMULATION - THIS PROPOSAL RESPONDS TO BRAIN INITIATIVE RFA-NS-20-006 AND AIMS TO ELUCIDATE THE NEURAL AND B | $824,807 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STATISTICAL METHODS AND DESIGNS FOR CORRELATED OUTCOME AND COVARIATE ERRORS IN STUDIES OF HIV/AIDS - PROJECT SUMMARY/ASBTRACT ELECTRONIC HEALTH RECORD (EHR) AND | $823,258 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE NEXUS OF TRAINED IMMUNITY AND STABLE IMMUNE COMPLEXES: IMPLICATIONS FOR AGING-RELATED CONDITIONS IN PLWH - PROJECT SUMMARY APPROXIMATELY 38.4 MILLION PEOPLE | $822,041 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ASSESSMENT OF NEW RECOMMENDATIONS FOR RSV VACCINATION IN 50-59 YEAR OLD HIGH RISK ADULTS ON SHORT- AND LONG-TERM CARDIORESPIRATORY OUTCOMES - PROJECT SUMMARY/AB | $818,076 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE SOUTHEASTERN HIV IMPLEMENTATION SCIENCE HUB: SUPPORTING THE SUSTAINED IMPLEMENTATION OF EVIDENCE-BASED CARE AMONG ACADEMIC, COMMUNITY, AND CLINICAL PARTNERS | $817,946 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | CONSEQUENCES OF CHRONIC NOISE EXPOSURE IN NONHUMAN PRIMATES - ABSTRACT NOISE-INDUCED HEARING LOSS (NIHL, INCLUDING CLINICALLY MEASURABLE AUDIOMETRIC THRESHOLD S | $817,862 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ANTISOCIAL BEHAVIOR IN FRONTOTEMPORAL DEMENTIA: BEHAVIORAL PHENOTYPES, NEURAL MARKERS, AND DECISION-MAKING MECHANISMS - PROJECT SUMMARY: ANTISOCIAL BEHAVIORS LI | $816,857 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | TESTING THE ROLE OF BELIEF UPDATING IN PERSECUTORY DELUSIONS - PERSECUTORY DELUSIONS, OR THE STRONGLY HELD BELIEF THAT OTHERS INTEND ME HARM, ARE DISTRESSING AN | $816,761 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISM OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) ON SPLANCHNIC VENOUS CAPACITANCE IN POSTURAL TACHYCARDIA SYNDROME - PROJECT SUMMARY POSTURAL TAC | $815,766 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | COMPARISON OF HIGH DOSE VS. STANDARD DOSE INFLUENZA VACCINES IN LUNG ALLOGRAFT RECIPIENTS - PROJECT SUMMARY INFLUENZA VIRUS IS A SIGNIFICANT PATHOGEN IN SOLID O | $812,893 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ABERRANT BASAL CELL METABOLISM DRIVES ALTERED EPITHELIAL DIFFERENTIATION IN COPD - PROJECT SUMMARY IN VITRO AND IN VIVO STUDIES INDICATE GOBLET CELL HYPERPLASI | $804,759 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE ROLE OF PREP IN GETTING TO ZERO - PROJECT SUMMARY/ABSTRACT PROGRESS IN HIV PREVENTION IN THE UNITED STATES (US) HAS STALLED, ACCORDING TO REPORTS FROM THE C | $795,821 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TARGETING MEDIATORS OF OXIDATIVE STRESS TO LIMIT HYPERINFLAMMATORY CELL DEATH MODALITIES DURING MYCOBACTERIUM TUBERCULOSIS INFECTION - PROJECT SUMMARY ONE OF TH | $792,355 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | EVALUATING THE SAFETY AND EFFICACY OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR PRE-PREGNANCY WEIGHT MANAGEMENT AND IMPROVED PREGNANCY OUTCOMES - SUMMARY WO | $785,385 |
| 2026 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | MICROBIOME, METABOLITES, AND ALCOHOL IN HIV TO REDUCE CVD (META HIV CVD) - THE OVERARCHING THEME FOR THIS PROGRAM PROJECT GRANT (PPG) IS THAT ALCOHOL ASSOCIATED | $781,176 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CIRCULATING PROTEOMICS TO PHENOTYPE THE DEVELOPMENT AND REVERSAL OF MYOCARDIAL REMODELING IN AORTIC STENOSIS - ABSTRACT: AORTIC STENOSIS (AS) CARRIES SIGNIFICAN | $769,658 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GENOMIC AND CIRCULATING PREDICTORS OF PAH RESPONSE | $769,368 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CLINICAL PHARMACOLOGY TRAINING PROGRAM | $767,302 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEXT GENERATION TRANSCRANIAL ULTRASOUND-BASED NEUROMODULATION USING PHASE SHIFT NANOEMULSIONS - PROJECT SUMMARY THIS PROPOSAL RESPONDS TO PAR-22-039 AND AIMS T | $765,144 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | VANDERBILT GENOME-ELECTRONIC RECORDS (VGER) PROJECT | $764,689 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HUMAN MONOCLONAL ANTIBODIES FOR ENCEPHALITIC ALPHAVIRUSES - SUMMARY: EASTERN EQUINE ENCEPHALITIS VIRUS (EEEV) IS A RE-EMERGING MOSQUITO-BORNE ALPHAVIRUS THAT CA | $762,403 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | HIV-RELATED TRAINING AND TECHNICAL ASSISTANCE 93.145 | EARLY INTERVENTION SERVICES | $759,340 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | YAP AND TAZ REGULATE ALVEOLAR EPITHELIAL CELL REGENERATION DURING LUNG REPAIR - PROJECT SUMMARY: PULMONARY FIBROSIS (PF) IS A CHRONIC RELENTLESSLY PROGRESSIVE I | $758,393 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DEVELOPING AND VALIDATING THE COMMUNICATING NEEDS WITH CARE PARTNERS SCALE (CONNECT): A PERSON-CENTERED BRAIN INJURY OUTCOME MEASURE - PROJECT SUMMARY IN THIS M | $756,415 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MAPPING THE DRUGGABLE GENOME OF THE HUMAN DUCTUS ARTERIOSUS: INTEGRATIVE OMICS AND HIGH THROUGHPUT SCREENING FOR NOVEL THERAPEUTICS - ABSTRACT THE DUCTUS ARTERI | $755,347 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE MOBILE HEALTH INTERVENTION IN PULMONARY ARTERIAL HYPERTENSION (MOVE PAH) STUDY - ABSTRACT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) HAVE REDUCED H | $755,346 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PROSPECTIVE INVESTIGATION OF CIRRHOTIC CARDIOMYOPATHY IN HUMANS - PROJECT SUMMARY CIRRHOTIC CARDIOMYOPATHY (CCM) IS A RECOGNIZED BUT UNDERSTUDIED AND NOT WELL U | $755,072 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE EFFECT OF ANSA CERVICALIS NEUROSTIMULATION ON AIRWAY PATENCY IN OBSTRUCTIVE SLEEP APNEA - PROJECT SUMMARY OBSTRUCTIVE SLEEP APNEA (OSA) IS A MAJOR SOURCE OF | $753,308 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CLONAL HEMATOPOIESIS AND INHERITED GENETIC VARIATION IN SICKLE CELL DISEASE - PROJECT SUMMARY SICKLE CELL DISEASE (SCD) IS ASSOCIATED WITH CHRONIC HEMOLYSIS, SY | $752,202 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | BREAST CANCER DIAGNOSTIC KIT TO IMPROVE EARLY DIAGNOSIS IN UGANDA - ABSTRACT: BREAST CANCER IN UGANDA PRESENTS A PRESSING PUBLIC HEALTH CHALLENGE, CHARACTERIZED | $751,816 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | IMPROVING PERSONALIZED BREAST CANCER CARE THROUGH A COMPUTERIZED PATIENT ADAPTABLE SHARED DECISION-MAKING SYSTEM (COMPASS) - THE PROPOSED RESEARCH ADDRESSES AN | $747,903 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HYPERTENSION-ASSOCIATED TRAINED IMMUNITY IN MYELOID CELLS IS A DETERMINANT OF ATHEROSCLEROSIS - PROJECT SUMMARY HYPERTENSION IS A LEADING MODIFIABLE RISK FACTOR | $746,512 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISTIC-BASED TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME - ABSTRACT: INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS) IS A DEBILITATING CH | $743,093 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | SEX-SPECIFIC GENETIC DRIVERS OF ALZHEIMER'S DISEASE ENDOPHENOTYPES - ABSTRACT AS THE POPULATION AGES, LATE-ONSET ALZHEIMER’S DISEASE (AD) IS BECOMING AN INCREAS | $741,851 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | RECONCEPTUALIZING DISEASE PROGRESSION IN PULMONARY FIBROSIS - PROJECT SUMMARY/ABSTRACT PULMONARY FIBROSIS (PF) IS A PROGRESSIVE, FATAL LUNG DISEASE. TWO FDA-APP | $739,660 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | SLEEP PROMOTING INTERVENTION TO IMPROVE DIABETES OUTCOMES AND EXECUTIVE FUNCTION IN ADOLESCENTS WITH T1D - PROJECT SUMMARY ONLY 17% OF ADOLESCENTS WITH TYPE 1 D | $737,312 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | AMERICAN SIGN LANGUAGE AND SPOKEN ENGLISH DEVELOPMENT OF YOUNG DEAF AND HARD OF HEARING CHILDREN - PROJECT SUMMARY ONE OF THE MOST HIGHLY DEBATED QUESTIONS FOR | $736,581 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | RANDOMIZED TRIAL OF A PERIOPERATIVE GERIATRIC INTERVENTION IN CANCER SURGERY - PROJECT SUMMARY WE PROPOSE A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (RCT) TO T | $735,047 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CREATING, EVALUATING, AND SHARING SYNTHETIC DATA FOR MULTINATIONAL HIV COHORTS - PROJECT SUMMARY/ABSTRACT PRINCIPLES OF OPEN SCIENCE OFTEN CLASH WITH REQUIREMEN | $734,162 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | TRANSLATING THE CLINICAL KNOWLEDGE OF MENDELIAN DISEASES TO REAL-WORLD EHR DATA TO IMPROVE IDENTIFICATION OF UNDIAGNOSED PATIENTS - PROJECT SUMMARY THE LAST TW | $730,538 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CLINICAL AND BIOCHEMICAL FEATURES OF METABOLIC DYSREGULATION IN FORMERLY PRETERM CHILDREN - IN THE US, ~100,000 BABIES ARE BORN PREMATURE AT <34 WEEKS GESTATION | $729,397 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MEASURING MEANINGFUL OUTCOMES FOR ADULTS WITH COCHLEAR IMPLANTS ACROSS THE LIFESPAN - PROJECT SUMMARY HEARING LOSS (HL) IS THE MOST COMMON SENSORY DISORDER IN T | $729,157 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VIRTUAL SYSTEMIC IDENTIFICATION OF DRUG TARGETS OF OBESITY CANDIDATE GENES - OVER 40% OF ADULTS ARE OBESE IN THE US. ALTHOUGH REDUCING CALORIC INTAKE AND/OR INC | $728,959 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HOST-MEDIATED ZINC SEQUESTRATION DURING ACINETOBACTER BAUMANNII INFECTION | $728,458 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERACTIONS OF INTRARENAL DOPAMINE AND CYCLOOXYGENASE-2 | $726,926 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | SALT MEDIATED CROSS TALK BETWEEN LYMPHATIC VESSELS AND IMMUNE CELLS IN KIDNEY DISEASE - SUMMARY LYMPHATIC VESSELS ARE ESSENTIAL TO MAINTAINING INTERSTITIAL FLUI | $726,267 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | EXTRACELLULAR VESICLE CARGOES AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS OF MALIGNANT PLEURAL EFFUSION - ABSTRACT /SUMMARY: AN ESTIMATED 1.5 MILLION PLEURAL EFFUSI | $726,231 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | THE THROMBOXANE-PROSTANOID RECEPTOR IN RADIATION-INDUCED PULMONARY FIBROSIS - PROJECT SUMMARY: RADIATION INDUCED LUNG INJURY IS A CRUCIAL DOSE-LIMITING FACTOR I | $725,891 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ARTIFICIAL INTELLIGENCE TO ESTIMATE EXTENT OF CGVHD FROM PATIENT PHOTOS - PROJECT SUMMARY / ABSTRACT LACK OF RELIABLE ASSESSMENT TOOLS IS A MAJOR OBSTACLE TO VA | $725,639 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | STUDIES ON THE STRUCTURE OF BASEMENT MEMBRANES | $724,530 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | GUT MICROBIOTA-RELATED MECHANISMS THAT IMPACT COLORECTAL CANCER RISK AFTER BARIATRIC SURGERY - ABSTRACT: BARIATRIC SURGERY, CURRENTLY THE MOST EFFECTIVE TREATME | $724,422 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | BUILDING LUNG CANCER RISK PREDICTION MODELS FOR FORMER SMOKERS: AN OMICS-BASED EPIDEMIOLOGIC STUDY - PROJECT SUMMARY LUNG CANCER IS THE LEADING CAUSE OF CANCER | $724,189 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | UNCOVERING COLORECTAL CANCER ETIOLOGY AND BIOLOGY BY INTEGRATING PROTEOMICS WITH OTHER OMICS DATA - PROJECT SUMMARY GENETIC FACTORS PLAY A SIGNIFICANT ROLE IN T | $723,593 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE ROAD TO DESTINATION THERAPY: DEVELOPING A DURABLE AMBULATORY MECHANICAL CARDIOPULMONARY SUPPORT FOR PULMONARY HYPERTENSION - PROJECT ABSTRACT PULMONARY HYPE | $722,404 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MOLECULAR MAPPING OF MICROBIAL COMMUNITIES AT THE HOST-PATHOGEN INTERFACE BY MULTI-MODAL 3-DIMENSIONAL IMAGING MASS SPECTROMETRY | $722,398 |
| 2026 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | DISCHARGEWATCH: NEXT-DAY PATIENT DISCHARGE PREDICTION WITH MULTIMODAL MODELS - PROJECT SUMMARY HOSPITAL DISCHARGE PLANNING IS CRITICAL YET OFTEN INEFFICIENT, WI | $722,210 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TAILORING DIABETES SUPPORT TO SOCIAL CONTEXTS FOR ADULTS LIVING WITH TYPE 2 DIABETES - PROJECT SUMMARY AMONG ADULTS WITH TYPE 2 DIABETES (T2D), DAILY DIABETES S | $721,957 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SOCIAL ISOLATION AND SOCIAL COGNITION IN ADOLESCENTS WITH TOURETTE SYNDROME - PROJECT SUMMARY / ABSTRACT CANDIDATE: KELLY WATSON, PHD IS ASSISTANT PROFESSOR IN | $719,709 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | DEVELOPMENTAL STUTTERING: POPULATION-BASED GENETIC DISCOVERY - ABSTRACT DEVELOPMENTAL STUTTERING IS A COMMON SPEECH DISORDER CHARACTERIZED BY PROLONGATIONS, BLO | $718,261 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ESTABLISHING CRITICAL TIME WINDOWS OF INFANT RSV INFECTION IN THE CAUSAL RELATIONSHIP OF RSV AND CHILDHOOD ASTHMA - PROJECT SUMMARY SIXTY YEARS OF OBSERVATIONAL | $716,191 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CLINICAL AND MECHANISTIC UNDERSTANDING OF RIGHT VENTRICULAR STEATOSIS IN PULMONARY ARTERIAL HYPERTENSION - ABSTRACT MOST PATIENTS WITH PULMONARY ARTERIAL HYPERT | $716,036 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLE OF HB-EGF IN RENAL EPITHELIAL CELL INJURY | $715,864 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | ENABLING TECHNOLOGIES FOR PRE-CLINICAL AND TRANSLATIONAL RESEARCH USING 3-DIMENSIONAL ADULT RETINA TISSUE CULTURE - ABSTRACT: 3-DIMENSIONAL (3D) CULTURES OF ANI | $714,844 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | OXGR1 IN RENAL INTERCALATED CELLS, SALT TRANSPORT AND DIURETIC EFFICACY | $714,418 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | PHENOTYPES AND ENDOTYPES OF RECOVERY FROM ACUTE DISORDERS OF CONSCIOUSNESS - PROJECT SUMMARY DISORDERS OF CONSCIOUSNESS (DOC) ARE STATES OF IMPAIRED AROUSAL AND | $711,408 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | VANDERBILT GENOMIC LEARNING HEALTH SYSTEM CLINICAL SITE - PROJECT SUMMARY ADVANCES IN POPULATION-SCALE GENETIC DATA LINKED TO THE ELECTRONIC HEALTH RECORD (EHR) | $711,274 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE ROLE OF TIE2 SIGNALING IN AORTIC VALVE REMODELING - ABNORMAL VALVE DEVELOPMENT CONTRIBUTES TO MANY COMMON CONGENITAL HEART MALFORMATIONS. DEVELOPMENTAL SIGN | $710,465 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE MULTIDIMENSIONAL PHENOTYPING IN CRITICAL CARE (MUSIC) CONSORTIUM: A PATHWAY TO PRECISION MEDICINE AT THE BEDSIDE - PROJECT SUMMARY CURRENT APPROACHES TO CLA | $708,263 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ENHANCING CLINICAL TRIAL ANALYSIS LEVERAGING BASELINE NEUROIMAGING DATA - PROJECT SUMMARY RANDOMIZED CLINICAL TRIALS ARE THE GOLD STANDARD FOR ASSESSING THE EFF | $707,033 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HUMAN M CELLS REQUIRE CORONIN 1A - PROJECT SUMMARY/ABSTRACT THE REGULATION OF LUMINAL SURVEILLANCE AND ANTIGEN SAMPLING ACROSS MUCOSAL SURFACES REMAINS AN IMPO | $706,382 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | IMPROVING NONINVASIVE ASSESSMENT OF RENAL MASSES THROUGH MRI CYTOMETRY-DERIVED CELL SIZE AND DENSITY - SUMMARY KIDNEY CANCER INCIDENCE HAS NEARLY DOUBLED IN REC | $701,332 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | DISCOVERY AND CHARACTERIZATION OF RARE VARIANT EFFECTS IN DILATED CARDIOMYOPATHY VIA LARGE-SCALE BIOBANK ANALYSIS - SUMMARY DILATED CARDIOMYOPATHY (DCM) AFFECTS | $699,408 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MODELING MORTALITY IN DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY: IDENTIFICATION OF SURROGATE OUTCOME MEASURES FOR DMD DRUG TRIALS - PROJECT SUMMARY/ABSTRACT DU | $699,395 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | LANGUAGE PROCESSING IN CONTEXT FOLLOWING TRAUMATIC BRAIN INJURY | $697,360 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | VANDERBILT STIMULATING ACCESS TO RESEARCH IN RESIDENCY (V-STARR) - THE GOAL OF THIS APPLICATION IS TO CONTINUE THE HIGHLY SUCCESSFUL VANDERBILT - STIMULATING AC | $696,332 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | SELECTIVE LOSS OF HLA GENE PRODUCTS IN DRIVING UNIQUE BREAST CANCER IMMUNOBIOLOGY - DESPITE THE SUCCESS OF IMMUNE CHECKPOINT INHIBITION (ICI) IN CANCER THERAPY, | $695,884 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | CLINICAL TRANSLATION OF MR CYTOMETRY - PROJECT SUMMARY THIS ACADEMIC-INDUSTRIAL PARTNERSHIP (AIP) GRANT AIMS TO TRANSLATE THE MR CYTOMETRY IMAGING TECHNIQUE INT | $694,929 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | PHYSIOLOGICAL AND PSYCHOSOCIAL ASPECTS OF REPRODUCTIVE HEALTH AFTER EARLY-ONSET COLORECTAL CANCER - SUMMARY DESPITE THE NUMBER OF ADULTS WITHIN THEIR CHILD-BEAR | $690,287 |
State business registration
- VANDERBILT UNIVERSITY MEDICAL CENTER TN, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
- VANDERBILT UNIVERSITY MEDICAL CENTER, INC. FL, Foreign nonprofit corporation (FORNP), Active, formed 2016-01-21
The same business name in the same state, from the state’s official registry data.
Trademarks
24 US trademarks, 15 live.
- VANDERBILT UNIVERSITY MEDICAL CENTER 24 marks, TN EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| TOTUM | 99185147 | 2025-05-14 | Pending application | TRTDXFAP, file of 2026-05-21 |
| NB | 99183011 | 2025-05-13 | Pending application | TRTDXFAP, file of 2026-05-21 |
| (design) | 87690093 | 2017-11-17 | Registered | TRTYRAP, file of 2026-04-03 |
| (design) | 87690086 | 2017-11-17 | Registered | TRTYRAP, file of 2026-04-03 |
| NASHBIO | 87690084 | 2017-11-17 | Registered | TRTDXFAP, file of 2026-10-07 |
| NASHVILLE BIOSCIENCES | 87690082 | 2017-11-17 | Registered | TRTYRAP, file of 2026-04-03 |
| MY SOUTHERN HEALTH | 86933416 | 2016-03-08 | Registration cancelled | TRCFECO2, file of 2024-03-27 |
| MY SOUTHERN HEALTH | 86933415 | 2016-03-08 | Registered | TRTYRAP, file of 2026-04-03 |
| BE ABLE. | 86556612 | 2015-03-06 | Registration cancelled | TRCFECO2, file of 2024-03-27 |
| FLULAPALOOZA | 86474947 | 2014-12-09 | Registered and renewed | TRTYRAP, file of 2026-04-03 |
The newest marks of the trademark owners above, matched to this record by name (and state).
In the news
54,214 news articles name this organization (February 2015 to November 2026); the latest 10:
- Long COVID symptoms may improve within 3 years, new study finds
wjcl.com, November 13, 2026 - Weill Cornell Medicine receives grant to track elder mistreatment
news-medical.net, November 13, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wxii12.com, November 13, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wtae.com, November 13, 2026 - Long COVID symptoms may improve within 3 years, new study finds
4029tv.com, November 12, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wmur.com, November 12, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wapt.com, November 12, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wdsu.com, November 12, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wbaltv.com, November 12, 2026 - Long COVID symptoms may improve within 3 years, new study finds
wesh.com, November 12, 2026
News article metadata and links: The GDELT Project (https://www.gdeltproject.org/). Matched by: Exact name match: "vanderbilt university medical center". A shared name is not proof of the same organization; how the matching works. Most in the news.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Vanderbilt University Medical Center | TN | State business registries | name and state |
| Business registration | Vanderbilt University Medical Center | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER, INC. | TN | State business registries | name and state |
| Business registration | VANDERBILT UNIVERSITY MEDICAL CENTER, INC. | TN | State business registries | name and state |
| College | Vanderbilt University | TN | Colleges and universities (IPEDS) | matched by the colleges loader: hospital (EXACT) |
| Contractor | Vanderbilt University Medical Center | TN | Nonprofit contractors (Form 990) | name and state |
| Plan sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | VANDERBILT UNIVERSITY MEDICAL CENTER | MA | Federal spending (USAspending) | EIN (EXACT) |
| Federal award recipient | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Federal spending (USAspending) | name and state |
| Lobbying client | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Federal lobbying (LDA) | name and state |
| Lobbying registrant | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Federal lobbying (LDA) | name and state |
| Payment recipient | Vanderbilt University Medical Center | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Vanderbilt University Medical Center | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Vanderbilt University Medical Center | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Vanderbilt University Medical Center | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Vanderbilt University Medical Center | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Vanderbilt University Medical Center | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | VANDERBILT UNIVERSITY, MEDICAL CENTER | TN | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Vanderbilt University Medical Center Dba Vanderb | TN | Open Payments (drug and device company payments) | name and state |
| Trademark owner | VANDERBILT UNIVERSITY MEDICAL CENTER | TN | Trademarks (USPTO) | name and state |
| Wikipedia article | Vanderbilt University Medical Center | Wikipedia (English) | EXACT: the same IRS employer identification number (EIN) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
NTEE code Hospitals and Related Primary Medical Care Facilities, TN first:
- GRACE MEDICAL CLINIC INC TN
- BIRTH NETWORK TN
- OUR LADY OF GUADALUPE TN
- COVENANT CHRISTIAN HEALING TN
- AVERROES CLINIC INC TN
- HARP INC TN
- COMPASSION NEIGHBORHOOD CLINIC INC TN
- RHEA COUNTY VOLUNTEERS IN MEDICINE TN
- KEYS OF HEALING TN
- GALLOWAY PROJECT TN
In other datasets, the same topic (Health) in TN:
- Form D issuer: American Addiction Centers, Inc. (Form D private offerings)
- Lobbying client: ACADIA HEALTHCARE (Federal lobbying (LDA))
Interests: Hospitals and Related Primary Medical Care Facilities · science:research_education · Health
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Census Tract 165, Davidson County, Tennessee, place (city or town) Nashville-Davidson, TN, county Davidson County, TN, state Tennessee; placed by its ZIP code (county and tract) and city name (place). The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).
- Jeffrey R Balser MD PHD was paid $16,481,139, 213.0 times the median household income in Nashville-Davidson, TN ($77,371), where 14.1% of residents live in poverty.
- Revenue of $8,674,383,028 is $12,569 per resident of Nashville-Davidson, TN (population 690,130).
- That revenue equals 35.76% of all household income in Nashville-Davidson, TN (313,513 households at the median $77,371, about $24,256,814,323).
- 38,678 employees is 56.0 per 1,000 residents of Nashville-Davidson, TN.
| Measure | Census tract Census Tract 165, Davidson County, Tennessee | Place (city or town) Nashville-Davidson, TN | County Davidson County, TN | State Tennessee |
|---|---|---|---|---|
| Population B01003 | 4,594 | 690,130 | 715,388 | 7,066,383 |
| Population, 2020 census P1 | 4,812 | 689,447 | 715,884 | 6,910,840 |
| Median age B01002 | 20.8 | 34.5 | 34.6 | 38.9 |
| Under 18 B01001 | 1.4% | 20.7% | 20.7% | 22.2% |
| 65 and over B01001 | 0.7% | 12.7% | 12.9% | 17.1% |
| Households B11001 | 763 | 313,513 | 324,907 | 2,824,277 |
| Foreign born B05002 | 13.2% | 15.3% | 15.0% | 6.1% |
| Median household income B19013 | $59,063 | $77,371 | $77,853 | $69,595 |
| Median family income B19113 | $78,715 | $98,376 | $99,460 | $87,314 |
| Per capita income B19301 | $13,918 | $49,061 | $50,640 | $39,437 |
| Poverty rate B17001 | 26.9% | 14.1% | 13.9% | 13.8% |
| Unemployment rate B23025 | 2.7% | 4.5% | 4.5% | 4.7% |
| Civilian labor force B23025 | 2,281 | 407,433 | 421,061 | 3,527,571 |
| Mean commute (minutes) B08013 | 13.5 | 24.7 | 24.7 | 25.7 |
| Bachelor's degree or higher B15003 | 82.5% | 48.0% | 48.4% | 31.1% |
| Housing units B25001 | 997 | 344,794 | 357,113 | 3,143,670 |
| Owner-occupied B25003 | 0.0% | 52.4% | 52.8% | 66.9% |
| Renters B25003 | 100.0% | 47.6% | 47.2% | 33.1% |
| Median home value B25077 | $-666,666,666 | $413,600 | $417,400 | $286,700 |
| Median gross rent B25064 | $1,854 | $1,586 | $1,582 | $1,189 |
| White, not Hispanic B03002 | 50.5% | 52.6% | 53.2% | 71.0% |
| Black B03002 | 17.2% | 24.5% | 24.3% | 15.4% |
| Hispanic or Latino B03002 | 6.5% | 14.1% | 13.9% | 7.4% |
| Asian B03002 | 19.3% | 3.5% | 3.4% | 1.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 165, Davidson County, Tennessee.
Comments